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ABSTRACT 
 
Background  
South Africa has one of the most severe HIV epidemics globally, with an estimated 737,000 
AIDS related deaths annually and over a million children rendered orphans due to AIDS in 
2006. However in 2007, the South African government made a giant commitment to dealing 
effectively with the AIDS epidemic by implementing a National Strategic Plan (NSP), which 
had as one of its principal objectives the provision of antiretroviral medications to 80% of all 
people in need of the treatment by 2011. By the end of June 2011, the rollout of antiretroviral 
therapy continued to be successful with 1.4 million persons started on antiretroviral therapy 
and  treatment initiation rates reaching 30, 000 per month.    
 
Patients have to subject to an uncompromising adherence of taking at least 95% of 
antiretroviral medication as prescribed, because poor adherence to ART leads to treatment 
failure, viral mutations and the development of drug resistance. Of major concern to ART 
programmes are the current obstacles that patients’ face in lieu of treatment.  
 
Aim  
The aim of this study was to explore the barriers to adherence to antiretroviral treatment 
among patients in a public ART programme in Vredenburg, Western Cape.  
 
Methodology 
An explorative qualitative study was conducted where data was collected through interviews 
with 18 patients receiving treatment from the Vredenburg hospital. Data was audio-tape 
recorded, transcribed in full and thematic content analysis done. 
 
Results   
The study identified awareness of HIV status, disclosure, unemployment, lack of transport, 
insufficient feeding, disability grants, alcohol and alternative forms of therapy as well as stigma as 
major barriers to adherence. Whereas inadequate follow ups, recklessness in the way patients’ 
HIV results were handled, long waiting times and the fear of picking up other types of infections 
from other patients in the OPD also came under major criticisms from patients. Finally, the 
sharing of experiences at clinic visits, good healthcare provider’s patient relationships, believing 
in the treatment, good treatment literacy, being a parent and having children to take care of, the 
use of pill boxes, social and spiritual support from family members and friends were identified as 
factors that positively influenced adherence.  
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Conclusion  
HIV/AIDS has been a stigmatized illness since its onset in the early 1980s and, these results 
highlight that such stigma has yet to dissipate in Vredenburg. Therefore, stigma and 
disclosure must remain at the forefront of the ART programme implementation in 
Vredenburg; while long term projects that can support ART users economically should be 
created through partnerships with non-governmental organizations and the government of 
South Africa to optimize adherence in the community.   
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CHAPTER ONE 
 
INTRODUCTION  
 
 
 
1.1 Background    
HIV/AIDS is one of the leading causes of death worldwide with an estimated 22.4 million 
people known to be living with HIV globally in 2008 (UNAIDS, 2009). Sub-Saharan Africa 
remains the most severely affected region accounting for 67% of all global HIV infections, 68% 
of all new infections among adults and 91 % of new infections among children (ibid).  Of the 
estimated total of 22.4 million people infected with HIV infections globally in 2008, South 
Africa had the highest number, with over 5.7 million people living with HIV, including 300,000 
children below the age of 15 years old (ibid). South Africa was considered to have the most 
severe HIV/AIDS epidemic, with an estimated 737,000 AIDS-related deaths and over a million 
children rendered orphans due to AIDS  related deaths in 2006 (Van Wyk et al., 2006; Shaik, 
2007). However in 2007, the South African government made a giant commitment to dealing 
effectively with the AIDS epidemic by appointing a new minister of health who pledged to 
implement a National Strategic Plan (NSP) that included a target of providing  antiretroviral  
drugs (ARV) to 80% of all people in need of the treatment by 2011 (NSP, 2007).  By the end of 
November 2009, over 940,000 patients were already enrolled on the national ART programme.  
 
Antiretroviral medications are essential components of comprehensive approaches to curbing 
the HIV/AIDS epidemic (Simon, Frick, Lockhart & Liebovitz, 2002). Remarkable benefits 
have been recorded globally especially in Sub-Saharan Africa from the use of ART in the 
management of HIV/AIDS, following their introduction in the early 1990s (Palella, 1998; 
Hogg, 1998).  Even though antiretroviral medications do not cure HIV/AIDS, they have 
demonstrated outstanding results in reducing the viral load of people living with HIV/AIDS 
(PLWHA), reinforcing their immune systems and hence curbing HIV/AIDS related morbidity 
and mortality (Holmes et al., 2007).  In low income countries such as Uganda, the use of ART 
has been acknowledged to decrease HIV transmission by 50% (Gray et al., 2003; Chi-Tai et al., 
2004; Spacek et al., 2006). ART have reduced mortality in HIV infected populations by 95% 
while significantly decreasing mother-to-child transmission of HIV (Mermin et al., 2008). The 
appropriate utilization of ART has equally improved the CD4 cell counts of HIV/AIDS patients 
thus changing the nature of AIDS from a disease with a death sentence to a chronic and more 
controllable illness (Ledergerber et al., 1999). 
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 However, in order to enjoy these massive benefits of antiretroviral medication, patients must 
subject to an uncompromising and long-term optimal adherence of taking at least 95% of their 
antiretroviral medication as prescribed (Miller & Hays, 2000). It has been established that 
poor adherence is well known to accelerate the progression of HIV to AIDS, the development 
of multidrug resistance and even death due to opportunistic infections (Weiser et al., 2003). 
 
1.2 Forms of Adherence  
According to WHO (2003), adherence is defined as the ability of patients to follow their 
treatment plans, take their different medications at prescribed times and frequencies, and also 
follow restrictions regarding their life styles, food and other medications. Adherence to ART 
of over 95% as prescribed by the doctors including restrictions regarding life styles, food and 
other medications is known as optimal adherence (WHO, 2003). This form of adherence has 
been proven to yield the most desirable health benefits of viral suppression and the 
improvement of the CD4 cell counts of HIV/AIDS patients (Miller & Hays, 2000; Paterson et 
al., 2000; Gross et al., 2001; Lyon et al., 2003). Adherence rates to ART of between 70% and 
89% are considered as sub-optimal adherence (Bangsberg et al., 2003; Hardy, 2003). Unlike 
other chronic diseases where sub-optimal adherence rates are acceptable, in ART sub-optimal 
adherence is associated with the harmful consequences of drug resistance (Bangsberg et al., 
2003; Hardy, 2003). It has been demonstrated that sub-optimal adherence levels of between 
70% and 95% are associated with the highest probability of developing drug resistance. This 
is because drug exposure at this level of adherence is insufficient to achieve viral suppression 
but still high enough to provide a selective pressure.  The selective pressure exerted by 
inadequate uses of ART causes rapid emergence of mutations and drug resistance. This puts 
the moderately well but not perfect adherers at even a higher risk of developing drug 
resistance compared to the poorer adherers (Bangsberg et al., 2003; Hardy, 2003).  
 
Hill et al. (2003) conducted a study to explore patterns and explanations of adherence to 
antiretroviral therapies from patients’ perspectives through 78 in-depth interviews with 
patients attending an HIV clinic in New Orleans and Louisiana. In this study most 
respondents did not consider taking ART for a few days as inadequate adherence vis-à-vis not 
taking it for several weeks or months. The perception by ART users that sub-optimal 
adherence to ART is acceptable is unsafe to ART programmes as it can mislead patients and 
cause them to develop drug resistance. It has been equally cautioned that when aiming to 
improve adherence great care should be taken to avoid increasing it just enough to put the 
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ART users at a high risk group of sub-optimal adherence (Hill et al., 2003). Further research 
on sub-optimal adherence and the factors influencing it, is critical in this era of rapid ART 
rollouts to avert the development of drug resistance.   
 
1.3 Forms of Non-adherence  
When patients fails to adhere to instructions given to them regarding their antiretroviral 
medications or follow restrictions regarding their life styles, food and other medications they 
are said to be non-adherent (WHO, 2003). Studies seeking to understand non-adherence to ART 
have identified three forms of non-adherence namely: erratic non-adherence, unwitting non-
adherence and intelligent non-adherence (Donovan & Blake, 1992).  
 
Erratic non-adherence 
Erratic non-adherence is the form of non-adherence in which patients understand their 
prescriptions and are willing to adhere  to the prescriptions, but they still skip doses because 
of other factors out of their control such as: forgetfulness, changing schedules or busy life 
styles or because they have not yet prioritized the management of their health problem. 
Erratic non-adherence is considered the most regular and most recognized from of non-
adherence in chronic diseases such as AIDS (WHO, 2003; Donovan & Blake, 1992). 
Documented strategies that have yielded good results in curbing erratic non-adherence for 
other chronic diseases which can be deployed to decrease erratic non-adherence to ART 
include: once dosing, learning new habits and the use of memory aids and pills organizers 
(WHO, 2003).  
 
Unwitting non-adherence  
Unwitting non-adherence is another form of non-adherence in which patients may be 
involuntarily non-adherent to prescribed therapies because they failed to understand fully the 
specifics of the regimen or the necessity of adherence (WHO, 2003). Studies in both urban 
and rural settings have demonstrated that 13% to 14% of patients often misunderstand their 
prescriptions (Bangsberg et al., 2001; Miller & Hays, 2000).  Some reasons for the prevalence 
of unwitting non-adherence to regimens include the use of pill bottles, or pill boxes or 
packages not carrying proper labels with clear dosing instructions.  This form of non-
adherence will most likely occur in settings where high levels of illiteracy predominate or 
where instructions are given to the patients through translators or in other languages not well 
mastered by the patients. It is of utmost importance to health care providers to therefore 
ensure that patients understand their ART regimens including food, water and life style 
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restrictions to enable them adhere properly to ART and obtain the health benefits associated 
with consistent adherence (Bangsberg et al., 2001; Miller & Hays, 2000). 
 
Intelligent non-adherence  
Intelligent non-adherence like other forms of non-adherence is the only form of non-
adherence in which patients calculatingly alter, discontinue or even fail to take their therapy 
as prescribed (WHO, 2003). Patients may exhibit this form of non-adherence in chronic 
diseases due to: feeling better, stigma and discrimination, fear of perceived short or long-term 
side effects, bad taste of the therapy and or the complexity of the therapy interfering with the 
daily lives of the patients (WHO, 2003). Though combating intelligent non-adherence may be 
intricate, understanding it can greatly enhance the development of strategies that will 
optimize adherence and the prevention of drug resistance in ARV users exhibiting this form 
of non-adherence.  
 
1.4 Challenges to Life-time Adherence 
Despite the immense benefits derived from appropriate antiretroviral therapy use to PLWHA, 
public health, and health care providers; sustaining ART adherence is still a major challenge 
to many ART programmes worldwide (Weiser et al., 2003). In South Africa sustaining 
adherence rates of greater than 95% to ART medications has been a challenge to both the 
healthcare providers and HIV/AIDS patients due to the many barriers that hinder them from 
achieving their desired treatment success rates (MSF, 2010). Presently, many ART 
programmes are concerned about the obstacles that patients are faced with which interrupt 
their commitment to ARV medications (Mombassa ART Project, 2004). Although some 
forms of supports have been provided by ART programmes to help patients adhere to 
treatment, in South Africa like in Botswana, Tanzania and Uganda, most common barriers to 
adherence faced by HIV/AIDS patients include: financial, social, cultural, religious and health 
care systems constraints (Hardon, 2006). The ART service providers themselves also face 
political, human resources, infrastructural and financial constraints that prevent them from 
achieving the desired service delivery goals (MSF, 2010). Given that adherence to ART 
medication is a dynamic process, current knowledge of the obstacles that interrupt HIV/AIDS 
clients from their daily commitments to taking ARV medications is of critical importance to 
ART programmes in many parts of the world.  
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1.5 Problem Statement  
According to the project manager of the HIV/AIDS initiative group which offers voluntary 
counseling and testing in Vredenburg, HIV stigmatization, discrimination and denial still 
persist in the town; and as a result of it, only a very few people come for HIV testing (Palitza, 
2010).  Most HIV infected people in Vredenburg only find out about their HIV status when 
they have repeated incidences of opportunistic infections such as TB; and by the time they get 
treated of the opportunistic infections to enable them start with their ART, it becomes too late 
(Palitza, 2010).  Although the TB/HIV Care Association, an NGO in Cape Town, has trained 
home-based care workers to support HIV/AIDS clients on ART in Vredenburg and in so 
doing counter HIV/AIDS related stigma in the community, no studies have been conducted in 
Vredenburg to ascertain the range and extend of the barriers these HIV/AIDS patients face 
while on treatment.  
 
1.6 Outline of the Mini-thesis  
The description of the study, its findings and recommendations are covered in: 
Chapter 1: Introduction  
Chapter 2: Literature Review  
Chapter 3: Research Methodology 
Chapter 4:  Presentation of Results  
Chapter 5: Discussion of Results  
Chapter 6: Conclusions, recommendations, suggestions for further research and the strengths 
and limitations of the study.  
 
Summary 
This chapter highlighted the present situation of the HIV epidemic and the rollout of ART in 
South Africa. It also looked at three major forms of non-adherence and the challenges to life-
time adherence to therapy. The chapter was then concluded with the problem statement for 
the study and an outline of the mini-thesis.  
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CHAPTER TWO 
LITERATURE REVIEW 
 
 
2.1 Introduction  
This chapter will focus on a succinct description of HIV care and treatment in South Africa, 
followed by a review of factors that influence ARV users to fall short in their daily 
commitments to taking their ARVs as prescribed by the doctors.  
 
2.2 HIV Care and Treatment in South Africa 
HIV testing  
In South Africa, there are numerous entry points into HIV care which include: VCT venues, 
prevention of mother to child transmission (PMTCT) programmes, clinics offering reproductive 
health and sexually transmitted infection (STI) services, hospitals, prisons, primary healthcare 
facilities and TB clinics (DOH, 2004). VCT services are usually offered free of charge in all the 
primary healthcare clinics and community health centers upon request by clients. Before an 
HIV test, pre-testing counseling is provided by a community health worker, while the actual 
testing is done by registered nurses and the results are made available between five to ten 
minutes (Ruud, Srinivas & Toverud, 2009). All clients who take the HIV test receive personal 
post-test counseling together with their HIV tests results. These counseling sessions are 
sometimes accompanied by appropriate support and advice depending on their HIV-status. A 
provider-initiated HIV testing and counseling (HTC) approach for all patients whose clinical 
presentations might result from underlying HIV infections, is now recommended by the South 
African development community (SADC) as a standard part of medical care for all patients 
attending healthcare facilities (Setswe, 2009). The approach has yielded better results than the 
previous VCT approach, as it is presently increasing HTC uptake and the timely identification 
of PLWHA who should be on HIV care by instigating HIV testing in all clients who use the 
healthcare facilities (ibid).  
  
Patient initiation on ART   
Following the South African 2010 clinical guidelines for the management of HIV and AIDS 
in adults and adolescences, the initiation of adults and adolescents on ART is based on both 
medical and psycho-social factors that are assessed by a multidisciplinary team of experts 
(DOH, 2010). However, the final decisions for initiation are made at the discretion of the 
health care provider (HCP) team, after taking into consideration the prognosis as determined 
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by the CD4 cell count and the viral load of the patients, the potential risks and benefits of 
ART as well as the readiness of the patients to start with long-term therapy (DOH, 2010). 
Positive patients not yet eligible for ART are usually transferred to wellness programmes for 
regular follow up and repeated clinical assessments for about 6 months, while those initiated 
on ART are still followed up at the district hospital for three to six months, to monitor 
adherence and any drug reactions (Ruud, et al., 2009). Even though loss of follow up 
sometimes occur, special records of patients who are expected to return to the PHC clinics are 
kept, should they not honour their appointments at the clinics. Common reasons for not 
respecting referral dates to report to the PHC clinics by patients include adverse drug 
reactions or poor responses to the therapy (Ruud et al., 2009). Nevertheless, patients who 
encounter complications are either referred to the district hospitals or can return to the PHC 
clinics on specific dates during which a doctor is available to consult them. In other cases, 
where appropriate expertise exists, ART may also be initiated at the primary and community 
level where the patients will receive counseling, nutritional support psychosocial support and 
appropriate social welfare evaluation when  necessary (DOH,  2003). Central in the 
achievement of good patient follow-up and continuity of HIV care are important linkages for 
care and support, facilitated by nurses and/or counselors in the communities through: 
subsidiary community-based services as home based care, care provided by traditional health 
practitioners, hospices, and calming care provided by a range of non-governmental 
organizations (NGOs), faith based organizations (FBOs) and support groups run by PLWHA.  
 
2.3 Barriers to Adherence  
Globally, a variety of obstacles are known to inhibit ART users from taking their medications 
as prescribed which have resulted in HIV/AIDS related morbidity and mortality. These barriers 
to adherence to ART have been documented and categorized as: socioeconomic, healthcare 
team and system-related, therapy-related and patient-related factors (WHO, 2003).  
 
2.3.1 Socioeconomic Barriers 
Demographic variables such as: age, gender, ethnicity and level of education are known to be 
inconsistent in predicting adherence (Moralez et al., 1998). The potency of demographic 
characteristics in influencing adherence to ART is closely examined below.   
 
Age 
 In a review of published articles and abstract reports on patient’s adherence to HIV medication 
regimens, Fogarty et al. (2002) found that personal attributes showed a mixed relationship in 
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which gender was not consistently related to adherence while younger age was associated to 
lower adherence.  Similarly, in a study carried out in Burundi, Cameroon and the Democratic 
Republic of Congo, Newman et al. (2011) demonstrated better adherence among older people 
compared to younger people. A number of factors related to: family issues, unreliable care 
givers, and fear of being different from their peers, unpalatable liquids and forgetfulness have 
been identified to contribute to poor adherence among young adults and children (Heyer & 
Ogunbanjo, 2006).  
 
Gender 
More often than not evidence regarding the relationship between adherence and gender is 
generally weak (Fogarty et al., 2002; Orrell, Bangsberg & Wood, 2003; Safren et al., 2005).  
Nonetheless, in Nigeria, being a woman and less than 35 years old have also been associated 
with poor adherence (Ozuchukwu et al., 2009). On the other hand, Godin et al. (2005) found 
that Canadian men were twice as likely to be adherent compared to the women. Similarly, 
lower adherence in women compared to men has been reported by Zorrila (2000) in the United 
States of America. This author explained that the multiple roles of women in their families as 
care givers and their fear of disclosing their HIV status to others are some of the remote factors 
resulting to the low adherence rates in women compared to men. Another  study that looked at 
adherence in injecting drug users (IDU) in Vancouver, Canada revealed that despite the  
universal access to free HIV treatment and medical care, female IDU were still less likely to 
access and adhere to ART (Tapp et al., 2011). In African communities as well, poor adherence 
among women have been linked to the fear of maltreatment from their husbands should they 
disclose their HIV status first in their relationships. This fear of abuse in marital homes as a 
result of being HIV positive causes women to hide or to stop taking their ARVs in the presence 
of their husbands or other family members (De Paoli, 2010).   
 
Ethnicity 
While Fogarty et al. (2002) reported lower adherence among minority groups in a review of 
published articles and abstract reports on patient’s adherence to HIV medication regimens, 
Wagner et al. (2002) found no association between adherence and ethnicity in African 
American males on ART in Los Angeles. Even though Mannheimer (2002) found that poor 
adherence was associated with non-white races, most of the studies  that have looked at 
adherence and ethnicity have been done in the developed world especially in North America 
and cannot be used as a prognostic evidence for Southern Africa (Heyer & Ogunbanjo, 2006). 
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2.3.2 Social Barriers  
Adherence to ART is a multifaceted problem that involves a wide range of variables. Social 
variables such as stigma and discrimination, disclosure and lack of social support are 
important factors that influence it.   
 
 
Stigma and discrimination  
From a sociological background, stigma is an attribute, behaviour, or reputation which is 
socially discrediting in a particular way; it causes an individual to be mentally classified by 
others in an undesirable, rejected stereotype rather than in an accepted, normal way (Reitzer, 
2006). As a result of stigma, people who suffer from certain chronic diseases as AIDS, 
leprosy and tuberculosis are treated differently; in most cases they are not treated decently.  
From the early 1980s, HIV/AIDS has been a stigmatized illness and as a result of the stigma 
attached to the disease, many HIV/AIDS patients have faced violence, rejection, avoidance, 
isolation, denial, loss of employment, social support and even divorces.  The fear of being 
stigmatized by love ones, friends or family members has prompted many patients to stop 
taking their medications in the presence of others or to skip doses (Nachega et al., 2006). 
Stigma is also known to be a central contributing factor to the low uptake of VCT, disclosure 
of HIV status, enrolment in ART programmes as well as adherence to therapy (Kagee & 
Delport, 2010).  
 
Disclosure  
Disclosure is defined as the ability of a person to make public secret information as an 
individual’s HIV status (Rabkin et al., 2005). The confidentially involved in most HIV testing 
ensures that results are made known to the individual alone. However, upon receipt of the results 
the individual has the discretion to keep it a secret or to tell others. Disclosure of HIV status is 
regarded as a fundamental step in accepting one’s HIV status and the readiness to live with the 
disease (Levy et al., 1999; Paxton, 2002). Some reasons why patients often find it difficult to 
disclose their HIV status are: the fear of rejection by their loved ones or family members or the 
fear of unfair dismissal from jobs as well as the fear of taking the blame of infidelity which may 
lead to divorce especially in societies where HIV stigma and discrimination persist (WHO, 2006).  
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On the contrary, disclosure of HIV status has enabled some patients to lobby for social, 
physiological, economical and spiritual support from family members, friends and love ones thus 
enabling them to step up their adherence (Mills et al., 2006).   
 
Lack of social support  
 A successful ART provision requires both medical care and a long term social and psychological 
support which includes the encouragement and the monitoring of adherence (Beals, et al., 2006).  
Persons on ARVs face the challenge of making sure that their medications are taken regularly and 
on time as well as respecting appointments for the replenishment of their medications over a 
prolonged period of time and such challenges require different forms of support (Hope & Israel, 
2007). Social, financial and psychosocial supports are examples of forms of support from love 
ones, family members, friends and treatment supporters that enable patients’ on-care to remember 
medication times, follow up visits and obtain food. Support is particularly important to HIV 
patients in the first three months of treatment when they are still very sick, reacting to drugs and 
battling to cope with their HIV status (Burrage & Demi, 2003). People who live in isolation and 
do not have psychosocial support have been associated with poor adherence (Williams & 
Friedland, 1997).  Nonetheless, good psychological and spiritual support from peer groups of 
PLHWA, treatment supporters, NGOs, churches and employers have also been associated with 
good adherence (Hardon et al., 2006; Farmer, 2001). 
 
2.3.3 Economic Barriers 
Poverty, unemployment and food insecurity are some of the economically related factors that 
also play an important role in adherence to ART as discussed below.  
 
Poverty  
Financial constraints are known to disrupt adherence to ARV in both developed and less 
developed countries. Literature has consistently revealed that patients on higher incomes have less 
difficulty with adherence compared to patient with low income levels (Pratt et al., 1998). In the 
early years of ART in South Africa, patients had to buy antiretroviral medications. As many 
patients were poor and could not afford the treatment due to financial constrains, and this led to 
treatment interruptions (DOH, 2008). Even though ART programmes have made ARVs more 
affordable to patients by providing them free of charge at the points of delivery, liquid cash is still 
needed to cover other costs such as transportation, medical tests and food supplements (Weidle et 
al., 2002). Financial constrains are most likely to hinder patients’ abilities to adhere to ART 
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particularly in rural areas and townships where patients are unemployed and cannot afford good 
nutrition as well as the transport cost to access good healthcare in the urban areas (Simoni, Frick 
& Liebovitz, 2002; Kagee, Le Roux & Dick, 2007).  
 
Food insecurity  
Many studies have highlighted the importance of good nutrition in the proper absorption of 
medications as an essential component of adherence. Thus the absence of good nutrition in 
patients on ART will lead to poor ART adherence outcomes in the patients (Larkin, 1998; 
Bukusuba, Kikafunda & Whitehead, 2007). Food insecurity has been documented as a common 
and an important barrier to accessing medical care and ARV adherence in Uganda (Weiser et 
al., 2010). In a qualitative study with 47 individuals living with HIV/AIDS recruited from an 
AIDS treatment programme at Mbarara and Kampala in Uganda, Weiser el al. (2010) revealed 
that food insecurity contributed to ART non-adherence and treatment interruptions or to 
postponing ART initiation in the following ways:  
 
1) ARVs increased appetite and led to intolerable hunger in the absence of food.    
2) Side effects of ARVs were exacerbated in the absence of food.  
3) Participants believed that they should skip doses or not start on ARVs at all if they could 
not afford added nutrition.  
4) Competing demands between costs of food and medical expenses led people either to 
default from treatment, or to give up food and wages to get medication.  
5) While working for food for long days in the fields, participants sometimes forgot their 
medications doses. 
Since food insecurity is a major health problem in many sub-Saharan Africa communities thus 
adherence to ART in these communities will be hindered if proper majors are not taken by ART 
programmes to alleviate the existing food insecurity (Uthman, 2008).  
 
2.3.4 Healthcare Team and System-related Barriers 
Inadequate human resources  
Whereas 36 out of the 57 countries that have a critical shortage of health workers are from sub-
Saharan Africa, these countries do not only faced  massive shortages of qualified health workers 
but also have  a high prevalence of HIV/AIDS that has further deteriorated their already weaken 
healthcare systems (WHO, 2006). These countries now encounter a double challenge of 
providing basic health care services to the population as well as trying to effectively deal with 
the burden of rapidly scaling up ARV (WHO/UNAIDS/PEPFAR, 2008). The shortage of 
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qualified doctors, pharmacists, nurses, laboratory technologists, counselors and other support 
staff has negatively impacted on the scaling up of ART services and the efficient management 
of ART programmes. This shortage of skill personnel in the health facilities has contributed to 
congestion in ART clinics, long waiting times, loss of adherence follow up and poor adherence 
counseling sessions (Ickovics & Meade, 2002). For example, in a study from Tanzania, long 
waiting hours and the spending of over ten hours in a hospital setting to access ART services 
during visits was reported to reduce clinic attendance and consequently hindered adherence 
(WHO, 2006).  Even though South Africa has 393 nurses and 74 doctors per 100,000 people, a 
high percentage of the health workers are found only in the private sector and acute shortages 
still exist in some public health facilities and the rural provinces of the Eastern Cape, Limpopo 
and Northern Cape (Breier, 2007). The principal reasons behind the shortage of health workers 
are long working hours, extra work loads involved in the provision of ART services, low 
salaries and little motivation from the employers. These poor working conditions have 
discouraged and pushed many qualified health workers to migrating from Africa to the 
developed countries for greener pasture (Schneider, et al., 2006). In an effort to mitigate human 
resource (HR) shortages, a strategy to shift some tasks from qualified health professionals to 
lower cadres or trained laypeople has been implemented in ART services (WHO, 2006). For 
example, in a Zambian, the use of adherence support workers (ASWs) in adherence counseling 
and treatment retention have shifted the workload from health care workers to ASWs without 
compromising  the quality of counseling and has also reduced loss to follow-up rates of new 
clients  from 15% to 0%  (Torpey et al., 2008). Although the use of non-health professionals in 
ART delivery systems can decrease HR constraints without compromising the quality of some 
services, they cannot effectively substitute the professional health workers in the delivery of 
ART services.  
 
Healthcare providers-patients’ relationship   
 An essential healthcare team and systems-related factor which has been shown to influence 
adherence to ART medications is the healthcare providers’ relationship with patients (Beyene et 
al., 2009; Godin et al., 2005). Poor healthcare providers’ approaches such as condemnatory 
behaviours, stereotyping, homophobia and failing to address cultural issues when administering 
care by healthcare providers are likely to negatively influence some HIV/AIDS patients to avoid 
accessing these healthcare facilities (Chesney, 2003). A qualitative study with physicians by 
Dzinza (2007) in the South East of Botswana demonstrated that the poor adherence of HIV/AIDS 
clients on ART was linked to the way they physicians communicated with the patients about 
ARV medications. Chesney (2003) urged healthcare providers to work with patients as “partners” 
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in care and also to involve representatives from the entire HIV community in ART programmes. 
On the other hand, good quality patient-healthcare providers’ relationship such as providing clear 
instructions to patients, with  adequate knowledge about the relationship between adherence and 
resistance, with kindness  and the willingness to include them in treatment decisions have been 
associated with good adherence. Good quality healthcare services that have the adequacy of 
referrals and the convenience of visiting the doctors with proper support from pharmacists and 
nurses are likely to positively influence adherence (Ammassari, 2002). In a study in Botswana, 
Weiser et al. (2003) found that 96% of patients were motivated to adhere to ART because the 
providers treated them with respect and dignity. Other good healthcare providers’ practices that 
have yielded good adherence results include: the writing of clear instructions on pills boxes, 
providing pill boxes to patients, asking questions of how the treatment can fit into daily activities 
and the use of medication events monitoring feedbacks (Carpenter, et al., 2000; Fogarty et al., 2002).  
 
2.3.5 Therapy-Related Barriers 
Complexity of regimens  
The complex nature of antiretroviral regimens with a high number of pills, number of daily 
doses, foods and fluids restrictions makes fitting regimens into daily living activities difficult 
and likely to negatively influence adherence (Ammassari et al., 2002; Deschamps et al., 
2004). The complex nature of antiretroviral regimens can also become a barrier to religious 
groups where fasting and restrictions from food and fluids are strictly observed by faithful 
members of such religions as Islam (Aadil, Houti & Mousasamih, 2004). 
 
The antiretroviral regimen HAART which consists of three or more ART medications that 
should be taken alongside with other drugs to prevent opportunistic infections makes the pill 
burden sum up to between 16 and 20 pills a day (Mombasa ART project, 2004). Adhering to 
such a large number of pills can be challenging and may lead to poor adherence outcomes 
(Mombassa ART Project, 2004).  Patients would if at all possible, choose taking two or less 
pills a day, with no dietary restrictions and the pills should be made small in size with all drugs 
combined in a pill of once a day dosing (Maggiolo, Ripamonti & Suter, 2003). However, 
interventions directed towards increasing adherence such as the use of pill boxes labelled with 
the dosing regimens and instructions, using timers and fitting medications into daily schedules 
are known to improve  adherence (Chesney et al., 2000; Fogarty et al., 2002; Simoni et al., 
2003). In order to resolve the pill burden of ART regimens, recent innovations have been made 
which consist of the production of one to three tablets which are taken twice a day (Stone, 
2002). While the complex nature of ART regimen has been identified as a barrier to adherence, 
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some studies from Africa have found no association between adherence and medical 
restrictions. For example in a South African study, Orrell et al. (2003) found no significant 
association between adherence and medication restrictions combined with taking over 10 tables 
per day. Also in another study in Botswana, even though 30% of the patients complained of the 
high number of pills, pill burden only hindered adherence in 5% of the patients (Weiser et al, 
2003).   
 
2.3.6 Patient-related Factors  
The most outstanding patient related factors that are constantly linked with poor adherence 
have been forgetfulness, being too busy, and change in daily routines, traveling without 
medication and difficult dosing schedules (Chesney et al., 2000; Fogarty et al., 2002; Simoni 
et al., 2003).  However, solutions such as the use of pill boxes labelled with clear instructions, 
the use of timers and fitting medications into daily schedules are currently being used to curb 
patient related barriers to adherence (Chesney, et al., 2000; Fogarty et al., 2002; Simoni et al., 
2003). 
  
Beliefs about ART  
Poor adherence has been associated with fear, skepticism, mistrust and myths regarding ART 
(Fogarty et al., 2002). Adherence to ART may be negatively influenced by a patient’s belief 
about the medication. Patients who have low confidence in the efficacy of medication and 
perceived minimal benefits from ART are less likely to be adherent (Mehta, Moore & 
Graham, 1997). Moreover lack of faith in medication combined with poor outlook for the 
future has been noted to leave patients with little motivation to adhere to proscribe 
pharmacotherapy (Peltzer et al., 2008). The belief that ARV could cure HIV has been noted 
to hinder adherence in the sense that when patients start feeling better they belief that they 
have been completely healed from HIV/AIDS and withdraw from the therapy (Eholie et al., 
2007).  
 
Substance abuse  
The use of substances such as alcohol and illicit drugs is associated with non-adherence 
(Palmira et al., 2005). In a qualitative study conducted in Brazil  between 2001 and 2002, in 
which some physicians cited patients’ social habits and routines as impacting negatively on 
adherence, the use of alcohol and illicit drugs was associated with non-adherence (Malta et 
al., 2005).  Substance abuse is known to negatively impact on adherence as it impairs the 
judgment of the patients, affects their concentration and memory, and their motivation to 
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continue taking the ART. It has been shown that, substances abusing patients tend to be more 
socially shattered thus making it difficult for them to receive any psychosocial and family 
support necessary for upholding adherence (Kagee, 2004). In communities with high rates of 
substance abuse, adherence may likely be negatively influenced in those patients involved in 
such social habits and routines.  
 
Cultural and religious beliefs 
In African societies, religious and cultural factors have major influences on people’s life-
styles and choice of treatment of illnesses due to the important role culture and religion play 
in healthcare in these societies (Van Dyk, 2001). There are growing fears by healthcare 
providers and ART users that the activities of traditional healers and religious prophets are 
leading to the concomitant use of ARV medication and traditional medicines or causing 
patients to switch from one form of treatment to another thereby compromising adherence 
(Nyika, 2007). According to Van Dyk (2001), people in several African communities 
believed that HIV is transmitted by witchcraft and as a result of this belief, visit traditional 
healers for solutions to their health problems. The traditional healers in response give their 
HIV and AIDS clients’ traditional medicines and instruct them to discontinue ARV 
medications or any other medications. Studies have also revealed high rates of traditional 
medicine utilization amongst PLWHA ranging from 15% to 79%, with some researchers 
suggesting that people infected with HIV use traditional medicines at substantially higher 
rates than people with other illnesses (Wiwanikit, 2003; Dhalla, Montaner et al., 2006).  
 
In South Africa, it is reported that 75% of HIV-infected people use remedies (muti) dispensed 
by traditional healers to cure HIV and AIDS (Ojikutu, Jack & Ramjee, 2007). The use of 
traditional medicines while on ART has been reported as a potential barrier to adherence 
(Dahab et al., 2008). Although the South African National ART guidelines state that patients 
must disclose the use of any other over-the-counter drug use and traditional medicines due to 
potential contraindications and adverse interactions, previous studies from the USA have 
shown that up to 70% of patients who use such therapies, do not inform their doctors (Dwyer 
et al., 1995). A number of patients have been known to resort to traditional medicine after 
experiencing side effects from ART but among such patients there is limited data available on 
the prevalence and patterns of traditional and alternative therapy use (Peltzer et al., 2008).  
 
In a study by Zou et al. (2009), it was found that a greater fraction of Pentecostal church 
members than Catholic or Lutheran church members believed that prayers and holy water 
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only, could cure HIV/AIDS with some Christians admitting that they would refuse ART in 
preference to prayers and holy water from their pastors for a cure to their HIV/AIDS. The 
response from 6.3% of a sample of Christians in rural and urban Tanzania said they would 
decline ART if they became HIV-infected and a doctor recommended them to starting ART. A 
significant percentage of those surveyed in the study believed that people who are HIV infected 
have not followed the words of God and that HIV is a punishment from God which can be 
reversed through prayers. Beliefs like these are likely to negatively influence adherence to ART 
in many Christian communities.  
 
Other evidence from a quantitative study in Uganda by Wanyama et al. (2007) showed that 6 
out of 558 HIV patients on ART discontinued their ART treatment because they believed they 
had been cured of HIV/AIDS through prayers.  Adherence can also be negatively affected in 
forms of religions where fasting, restrictions from food and fluids are strictly observed by 
faithful members such as in Islam during Ramadhan (Aadil, Houti & Mousasamih, 2004).  
  
2.4 Conclusion  
Though this literature review has looked at socioeconomic, healthcare team and system-
related, therapy-related and patient-related barriers to adherence, it is hoped that on 
completion of this study the findings from the barriers patients face while taking their ARVs 
in Vredenburg will fill in gaps in the literature.   
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CHAPTER THREE 
 
METHODOLOGY 
 
 
In this chapter, the aim, objectives, research design and method as well as the demographic 
characteristics of the patients are presented.    
 
3.1 AIM    
This study aimed to explore barriers to adherence to antiretroviral among patients in a 
regional hospital in Vredenburg, Western Cape.  
 
3.2  SPECIFIC OBJECTIVES 
• To describe the experiences of HIV/AIDS clients in Vredenburg about accessing 
ART. 
• To explore social and cultural factors that influence adherence to antiretroviral 
medication in Vredenburg.  
• To identify factors related to treatment regimen that influence adherence in 
Vredenburg.     
• To identify healthcare factors that influence adherence in Vredenburg.  
• To identify economic factors that influence adherence to antiretroviral in Vredenburg.  
 
3.3  Study Design  
A qualitative paradigm was employed for this study. According to Stommel and Wills (2004), 
a qualitative research focuses on interpretive, non-numerical, narrative interpretations and 
does not does not put emphasis on quantitative measures. As a result of the sensitive nature of 
the topic, the researchers employed an exploratory qualitative study approach that allowed the 
participants to tell their story in their own words so that the researcher could explore the 
factors that influence adherence to ART in Vredenburg. The choice of a qualitative approach 
in this study was motivated by the fact that, the researchers were interested in a rich data from 
the participants to enable an accurate description of the experiences of patients on ART as 
well as those factors that influence adherence in Vredenburg, by letting them tell their story in 
their own very words. The qualitative method permitted the researchers to explore and bring 
out those values, beliefs and life experiences related to ART adherence that would not have 
been easily achieved by a quantitative approach (Meyer, 2000). Through this approach the 
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researcher was able to uncover the obstacles that patients on ART faced that interrupt their 
commitment as well those factors that influenced them to visit religious prophets, traditional 
healers and or seek for alternative therapy to provide solutions or cure to HIV/AIDS in 
Vredenburg because the approach is best suited for studies that are aimed at exploring health 
behaviours (Pope & Mays, 1995).  
 
3.4 Study Setting  
Vredenburg is a small town of the West Coast in the Western Cape Province of South Africa, 
located about some 138 Kilometers to the north of Cape Town. It is the capital of the 
Saldanha Bay Local Municipality in the West Coast District and also a conglomeration of fish 
factories, local services such as banks, hospitals, shopping malls and a local tourist attraction 
of the Fossil Park. According to the population census of 2001, Vredenburg had a total 
population of 31,000 people. Most of the people in Vredenburg speak Afrikaans followed by 
isiXhosa and a few of the population speak English (Korpela et al., 2008).  
  
Among other (STIs), HIV has a high prevalence in the town. Between 2001 and 2004 the HIV 
prevalence in the community increased from 8.9% to 13.0% in 2004 (Shaikh et al., 2006). 
Despite the numerous HIV awareness campaigns that have been launched by the South 
African Government and civil organizations throughout the past decade, the Vredenburg 
health officials revealed that stigmatization, discrimination and denial of HIV still persist in 
Vredenburg (Palitza, 2010).  
 
3.5 Study Population 
The study population comprised of all adult male and female HIV and AIDS patients who 
were enrolled in the Vredenburg provincial hospital ART programme for greater than six 
months and the health care providers of the health facility who were actively involved in the 
ART programme at the time of the study such as: clinicians, nurses, counselors, health 
surveillance assistants (HSAs) and pharmacy technicians. A study population is an entire set 
of people, objects, or events of concern to a research study from which a sample is selected 
Williams, Tutty and Grinnel (1995). 
 
3.6 Sampling Procedure  
Purposeful sampling was employed to ensure that a rich variety of cases of poor adherers in the 
Vredenburg provincial hospital ART programme were all well represented. Purposeful 
sampling is a strategy often designed to enhance understanding of selected individuals or 
groups’ experiences or for developing theories and concepts. Researchers seek to accomplish 
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this goal by selecting “information rich” cases that are individuals, groups, organizations or 
behaviours that provide the greatest insight into the research question Kelly et al. (2000).  
Patients who had been enrolled on the ART programme for greater than six months and were 
physically and mentally able to undergo an in-depth interview were identified and contacted by 
a nurse or the doctor working on the programme. Other patients who fulfilled the eligibility 
criteria were sorted by designated clinicians and nurses using the medical records at the health 
facility. Eligible participants were contacted and provided with an explanation of the purpose of 
the study. Patients who did not fulfill the eligibility criteria included those patients who were 
not physical and mentally fit for in-depth interviews or patients who could not be reached by 
any means or were patients who were not yet eligible for ART and were transferred to wellness 
programmes for regular follow up and repeated clinical assessments for 6 months. Finally a 
sample of 18 information rich patients was purposefully drawn from those patients who met the 
eligibility criteria and who were willing to participate in the study.  
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Table 1: The Demographic Characteristics of the Patients 
 
No Name Age Sex Race   Place of birth 
 
Marital 
status 
Parental 
status 
Education Employment Date tested 
for HIV 
Date started 
with ARVs 
1 Julian 38 M Coloured Mauritzburg Single None Standard 8 No 2005 2005 
2 Thumeka 33 F Colored Malmesbury Widow 2 girls  Standard 8 No 2009 2009 
3 Kuthala 38 F Black Eastern Cape Widow 2 girls  Standard 9 No 2002 2007 
4 Rachael 25 F Coloured Vredendburg Single 1 girl  Standard 9. No 2004 2005 
5 Christine 38 F Black Northern Cape Single 1 girl  Grade 12  Yes 2005 2005 
6 Abraham 28 M Coloured Langebaan Single None Grade 10 No 2002 2002 
7 Susanna 63 F Coloured Lamberts Bay Single  None None No 2009 2009 
8 Richard 29 M Black Durban Single None Grade 9 Yes 2006 2006 
9 Reginah 45 F Black Queenstown Single None Grade 11 No 2007 2008 
10 Velda 32 F Coloured Siyabonga Married  2 boys 1 girl Grade 9  Yes 2004 2004 
11 Amanda 45 F Coloured Vredenburg Divorced  3 sons Grade 7 Yes 2006 2007 
12 Ben 51 M Black  Not Info  Single None Not known No 2009 2009 
13 Nontsikelelo 18 F Black Eastern Cape Married None Grade 11 No 2007 2007 
14 Alida 32 F Coloured Vredenburg, Boy friend 2 Children  Grade 8 Yes 2001 2001 
15 Michael Britton 51 M Coloured Saldanha Single  None Grade 7 No 2003 2003 
16 Anna  60 F Coloured No info Single 3 children None No 2004 2005 
17 Elsie  53 F Coloured Williston Single 2 daughters 1 
boy 
Not known No 2008 2008 
18 Joslin 31 F Coloured Saldanha Single 1 boy Grade 8 No 2007 2007 
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3.7 Data Collection  
The main source of data for the study was semi-structured in-depth interviews with non-
adhering patients that were audio-taped and transcribed verbatim. The use of audio tape 
recorders allowed for much fuller records to be taken than the written note questionnaires 
methods. Kumar (1995) recommends audio tape recorded interviews for a qualitative study like 
this one, since such interviews are suitable for both adults and children who are literate or not 
literate and it also allowed the respondents to express their feelings, beliefs, knowledge and 
points of view easily; while equally permitting an immediate verification of answers, expression 
of ideals and clarification of points made during the process of interviewing. Non-adhering 
patients were interviewed based on the obstacles they face that interrupt their commitment to 
their ART medications as well as those factors that motivated them to take their ART.  The 
semi-structured interviews employed, encouraged the patients to talk freely and therefore 
presented their information easily on the factors that influenced their adherence (Robson, 
1993).The interviews were conducted in the language of the participants’ choice and at a place 
of their choosing thus encouraging them to talk freely about their feelings, illnesses and other 
experiences. The participants’ voices were of optimum importance and the interviewers were 
guided by the participants’ responses in deciding when to probe the emerging themes. An 
interview guide was also compiled and used throughout the study to ensure standardization and 
consistency across the interviews with the participants (Appendix B). Field notes were taken 
and the raw data as well as the field notes were later expanded and re-written into well-
organized field notes, which also formed part of the data set.  
 
3.8 Data Analysis  
At the beginning of the data analysis, the transcripts were carefully read several times while 
taking note of similar topics, which were then grouped and arranged manually into major topics. 
Thematic analysis was done on the first set of twelve transcripts following the five stages of 
thematic analysis illustrated in Pope et al. (2000) which are: the familiarization stage, the theme 
identification stage, the indexing stage, the charting stage and the mapping and interpretation 
stages. In the process of familiarization, the transcripts and field notes were read through 
repeatedly while taking note of important themes, words and phrases that emerged from the 
transcripts and field notes. The next step of the data analysis was the identification stage; in 
which major themes, important words and phrases were written down and decontextualized in 
order to identify the main codes, themes and subthemes. Finally, the variables that influenced 
adherence to ART in the regional hospital of Vredenburg were identified and placed under the 
following groups: awareness of HIV status, economic factors, social factors, and health team 
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and system factors, therapy related factors, patient related factors, cultural factors, and 
institutionally related factors. The indexing stage was the third stage of the data analysis in 
which concepts were put side by side while sub-themes were regrouped into major themes and 
this was submitted several times to the supervisor for approval. Once the first two steps of the 
data analysis were approved, the researcher then repeated the same procedure on the remaining 
six transcripts and compared the two sets of data analyzed. After comparing the two sets of data, 
the factors that influenced adherence that were not found in the first set of data analyzed were 
then added as well as important quotes. Indexing was the third stage of data analysis, at this 
stage transcripts were orderly arranged with numerical codes from the index. Charting was done 
in the fourth stage of the analysis in which similar topics were then grouped together according 
to the appropriate framework to which they related forming the charts. Mapping and 
interpretation was done in the last step of the data analysis; at this stage the identified themes 
were grouped and interpreted in a meaningful way guided by the research objectives, the 
emerged themes and also supplemented with extra information from the literature search as 
guided in Mays and Pope (2000).  
 
3.9 Rigour 
When carrying out a qualitative research like this one, rigour is of paramount importance to 
ensure that results and interpretations obtained from the study are trustworthy and credible.  The 
basic approach used to ensuring rigour in qualitative research includes: a systematic and self- 
conscious research design, data collection, interpretation and communication (Mays and Pope, 
1995).  
 
Trustworthiness 
The trustworthiness of the study was addressed through ensuring credibility, transferability, 
dependability and conformability according to Lincoln and Cuba (1985).  
 
Credibility 
In order to ensure credibility in the study, the following steps were taken: the participants 
were allowed to share their experiences without being judged, the researcher endeavored to 
establish a good relationship with the participants to respond freely about their experiences 
during the interviews. Also, during the interviews, facial and body expressions were 
documented in a notebook by the interviewer and intergraded later into the field notes. The in-
depth interviews were transcribed verbatim and field notes were further reviewed to ensure 
that non-verbal information was not lost but integrated into the data. The field notes were also 
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numbered accordingly to eliminate the possibility of missing out any data as guided by 
Denzin and Lincoln (1994). An interview guide was compiled and used throughout the study 
to ensure standardization and consistency across interviews with participants. The researcher 
worked together with the supervisor of this mini-thesis throughout the process of the research 
design, data collection, and data analysis. In addition to this, many meeting sessions were held 
with the supervisor and during such meetings the researcher presented the any difficulties that 
were encountered during the research to the supervisor and solutions were immediately sorted 
out. Lastly, during data analysis the results of the study were triangulated with raw data and 
field notes that were expanded and re-written into well-organized notes and then together with 
other sources reported in the literature the data were examined to validate conclusions about 
meanings.  
 
Transferability  
To meet the criteria for transferability, the researcher provided in the report, the aim, 
objectives, research design and methods including the demographic characteristics of the 
participants as well as the research findings. The researcher made sure that the raw data and 
field notes that were expanded and then re-written into well-organized field notes that formed 
part of the data set, were kept in secured place for future cross checking or verifications. The 
detailed information provided in the report ensured the medium through which the study 
findings could be applied or transferred to other situations. 
 
Dependability  
To make sure that the aspect of dependability was taken care of, the researcher shared the 
transcripts with experienced researchers at the University of the Western Cape who 
independently did an analysis and compared notes. The data analysis was then checked for 
differences and similarity, and where discrepancies occurred they were resolved through 
‘member checking’ with the different researchers.  
 
Conformability 
To meet the criteria for conformability, the researcher held several meetings with the 
supervisor during which the approach to data collection and decisions about what data was to 
be collected as well as the interpretation of data that was to be collected were taken and 
during these meetings minutes were taken.  This step was important in ensuring that other 
knowledgeable researchers could also arrive at the same conclusions about the data as we did.  
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3.10 Ethical Considerations  
The ethical approval for this study to proceed was sought from the School of Public Health, in 
the University of the Western Cape and the City of Cape Town Health Department’s Ethical 
Committees. The researcher visited the Vredenburg hospital health officers to plead for 
permission to make use of the hospital’s resources for the study. The report of the finding of 
the study adhered to the principles of clarity, honesty, comprehensiveness and accountability.  
Participation in the study was voluntary and the participants were free to withdraw from the 
study at any stage without sustaining any penalty for withdrawing. The researcher  ensured  
that no risks was involved in participating in this study, by making sure that all information 
collected from the participants was treated with all confidentiality. No other persons had 
access to this information except the researchers. An inform consent with a brief explanation 
of the purpose and nature of the study was provided to the participant to sign as an agreement 
to participant in the study (Appendixes A). In a situation where a conflict came up between 
the researchers and the participants, the interest of the participants took precedence. All 
interviews were conducted in the language of preference of the participant and at a time and 
place convenient to the participants.  
 
 
 
 
CHAPTER FOUR 
 
RESULTS  
 
 
In this chapter the results of this study will be discussed along the themes and categories that 
were derived from the data; where applicable direct quotes were used to substantiate relevant 
results. The data collected from the interviews with 18 participants was organized around the 
following themes: a) Awareness of HIV status; b) Economic barriers; c) Social barriers; d) 
Health team and system barriers; e) Therapy related barriers related barriers; f) Patient related 
barriers; and g) Cultural barriers. The table below shows an outline of the themes, sub-codes 
and codes from the data analysis.    
   
Table 2:    Themes, Sub-Themes and Codes from the Data Analysis 
 
THEMES SUB THEMES CODES 
1.  Awareness of HIV 
     status of patients  
1.1  Circumstances leading to 
HIV testing 
- Protracted illnesses 
- Pregnancy 
- Providers initiated HIV tests 
- VCT 
1.2 Acceptance of HIV 
diagnosis 
-     Denial of HIV results  
- Shocked by HIV results 
- Not surprised by HIV results  
1.3  Disclosure - Partial disclosure  
- Full disclosure  
2. Economic barriers 2.1 Poverty 
 
- Lack of finance for needs  
- Lack  of money for transport 
- Food shortage 
- Disability grant 
2.2 Unemployment 
 
- Lack of a source of income   
- Loss of employment  
  
25
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THEMES SUB THEMES CODES 
3. Social barriers 
   
 
 
 
 
 
 
 
 
 
 
3.1 Unintended  disclosure of 
HIV status 
- Fear  of unintended disclosure 
by talking to community HIV 
care providers  
- Fear of unintended disclosure 
leading to the clandestine 
buying of ART  
3.2 Stigma and discrimination - Peer influence  
- Humiliation  
- Rejection  
3.3 Social support - Lack of family support  
- Emotional distress  
- Lack of moral support 
- Lack of spiritual support  
4. Health team and 
     system barriers  
 
4.1 Treatment literacy - Misunderstanding of 
prescriptions retractions  
- Misunderstanding of 
      prescriptions  
- Poor HIV counseling  
4.2  Quality of care  - Long waiting times 
- Inconsistent doctors   
- Lack of confidentiality  
- Dissatisfaction with the 
location  of the ART clinic  
- Fear of picking up different 
infections from other patients 
in the OPD  
- Lack of follow up  
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THEMES SUB THEMES CODES 
5. Therapy related 
     barriers   
5.1  Side effects - Discomfort 
- Dizziness   
- Rashes  
- Loss of appetite 
- Drug interactions  
- Sleepless nights  
- Stress  
- Depression   
- Drowsiness  
- Fatigue and low performance 
at work  
5.2 Feeling well - Carrying on with normal life 
styles  
- Stop treatment  
6. Patient related  
     barriers   
6.1 Substance abuse - Alcohol consumption 
- Tobacco use 
6.2 Emotional distress  - Forgetfulness  
- Confusion of doses 
6.3  Fatigue  - Hard work 
- Tiredness  
7. Cultural barriers   7.1 Use of traditional 
medicine and the 
activities of traditional 
healers  
- Use  traditional concoctions to 
cure HIV  
- Simultaneous use of traditional 
concoctions while on ART  
7.2  Religious  beliefs - Believes that traditional 
concoctions can cleanse 
patients internally of HIV 
- Believes in holy water  and 
prayers for the cure  HIV  
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4.1  Awareness, Acceptance and Disclosure of HIV Status  
4.1.1 Awareness of HIV Status   
The circumstances that made the respondents in this study to know their HIV status were 
placed under four groups namely: conditions of protracted illnesses, conditions of pregnancies, 
providers initiated HIV testing and voluntary HIV testing.  
 
 Awareness of HIV status through conditions of protracted illnesses 
In general, most male respondents tested for HIV only when they were suffering from 
protracted illnesses that required HIV tests to assist the medical diagnosis to their health 
problems.  
 
“I got tested for HIV because I was very sick and was taken to the hospital 
where they tested me for both HIV and Tb” (Male, 28 yrs).  
 
Awareness of HIV status through conditions of pregnancies 
Comparatively, a majority of the female respondents who had unprotected sex sometimes in the 
past and  accessed prenatal care during pregnancy became aware of their HIV statuses only 
through the compulsory HIV tests that were administered to them during pregnancy to prevent 
mother to child transmission of HIV.  
 
“I was five months pregnant…then I was tested” (Female, 25 yrs).  
 
Awareness of HIV status through provider initiated HIV testing  
Only a single female respondent in the study knew about her HIV status through a provider 
initiated HIV test that she took during a visit to the hospital for a different health problem.  The 
60 years old female respondent mentioned that when she went to the Groote Schuur hospital for 
her eyes and it was suggested that she test for HIV. When she did the test and the results came 
she found out that she was HIV positive and did not want to believe it at first.   
 
Awareness of HIV status through VCT 
Once more, just one female respondent knew her HIV status through a voluntary HIV test.   
The 38 years old female respondent mentioned that, she was reckless with her life in the past 
but when she was counseled during a peer counseling course that she attended, she decided to 
do the HIV test and found that she tested HIV positive.  
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“After my course, my Peer counseling course I, I, I started, I got tested for HIV, 2003, 
the same year”… “Yeah, Yeah, I had an idea because I was, I was a supervisor in first 
aid and we were careless with our, ourselves” (Female, 38 yrs).  
 
4.1.2 Acceptance of HIV Diagnosis  
Three categories of acceptance of HIV diagnosis were recorded in the study. In the first 
category are placed those respondents who at first denied their HIV diagnosis, this was 
followed by the second category of respondents who were shocked by their HIV diagnosis. In 
the last category, are found those respondents who were not very surprise by their HIV results 
because they were not taking HIV prevention seriously and thus prepared their minds to receive 
their HIV test results. 
 
Respondents who denied their HIV diagnosis  
A 28 years old male respondent denied his HIV results at first and had to be taken to a 
psychologist for counseling to come to terms with his HIV status. Similarly, a 53 year old 
female respondent denied her results at first and only came to terms with it after receiving 
confirmatory results from three different doctors.   
 
“Ja-ja-ja-ja-ja, ek was, ek weet nie hoe, ek meen.... I didn’t know how to accept it; but 
as time when on I met some other people with the same disease and we talk about it 
when we meet  at the clinic  and it made me feel a little bit better (Male, 38 yrs).  
 
This 38 years old male respondent denied his HIV diagnosis at first because he thought he 
could never become infected with HIV like other patients in the community. After constant 
counseling combined with exchange of experiences and discussions with other patients at the 
ART clinic the patient was able to come to terms with his HIV status.   
 
Respondent who were shocked by their HIV diagnosis   
Many respondents were shocked by their HIV diagnosis. What made some respondents more 
worried about their HIV diagnosis was how to cope with HIV for the rest of their lives while 
others were more concern about the feature of their children if they died prematurely from 
HIV/AIDS.  
 
“It is for the rest of my life…And I want to ask if... what I think in my life. When I think 
about my children, mean my children are still small. What they’re going to do if I’m 
dead and not there?”(Female, 33yrs) 
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Respondents who were not very surprise by their HIV diagnosis  
Those respondents who did not take HIV prevention seriously were not very surprise by the 
HIV results.  
 
“I had an idea because I was, I was a supervisor in first aid and we do lot of 
carelessness we did a lot of carelessness things with ourselves.” (Female, 38 yrs).   
 
The 38 years old female respondent above admitted that, she had an idea of her HIV test results 
before it was disclosed to her because she knew she did not take HIV prevention seriously in 
her past social life. Another female respondent also admitted that she did not take HIV 
prevention seriously and blamed her present HIV status on her reckless past life in which she 
had unprotected sex with different men for financial gains.    
 
 
“No you see the truth is that,  during  the stressful days that there was no money, you 
fuck the next person, fuck the world out there and no one can tell me it’s my life I will 
do as I wish but at the end of the day who are you going to blame every day, you blame 
yourself” (Female, 38 yrs).   
 
4.1.3 Disclosure of HIV Status  
Two forms of disclosures were recorded namely: partial and full disclosures. Most respondents 
at first disclosed partially to friends, aunts, uncles, family members’ healthcare officials or 
other HIV positive patients and later on disclosed fully in order to gain some forms of  
financial, psychological, moral, material and spiritual support.   
 
  
Partial disclosure  
According to some respondents they decided to disclose partially because of they were afraid of 
stigmatization, rejection and social exclusion or because they had an inner feeling of shame. As 
such they carefully selected those people they trusted would not stigmatize and or discriminate 
against them and who will also be supportive to them financially, morally or materially and 
spiritually.  
 
“I haven’t told anybody but my aunt… My mother knows and my sister’s knows and one 
of my aunt’s, my uncle and my boyfriend also know but not any other people.” (Female, 
33 yrs). 
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This respondent carefully selected those people she trusted will keep her HIV status 
confidential and will not stigmatize against her and then disclosed her HIV status to them.  
 
“The news will go also to other people and maybe they will see me and they say ‘ooh, I 
don’t want to go to, walk with that one or eat with that one’ you know, some of your good 
friends if they see you are on ARV or have, HIV then they don’t want to be friends with 
them” (Female, 33 yrs).  
 
Other respondents carefully selected only their immediate family members and confided in 
them their HIV status.   
 
“Same with… and my brothers, they know, my mother know, my father know, they all of 
them living....They support me” (Male, 38 yrs) 
 
Many patients preferred disclosing their HIV status to other HIV positive patients on the 
background that, other HIV patients were not going to be of any harm to them because they all 
shared one thing in common which was their HIV positive status.  
 
“I would be able like, hmm, becoming close friends, very close because for me it’s like 
we have the ‘same sickness”… (Female, 25 yrs).  
 
Full disclosure  
In this group, the respondents started by disclosing their HIV partially to a selected group of 
people but as time when on, they saw the need to disclose fully either because they wanted to 
take off the burden of carrying the secret of being HIV positive from them or because they 
wanted to gain some form of support or create HIV awareness in the community.    
 
“For me to disclose is in the hands of God, I had to start to set myself free from the world 
outside and pray to God and he was going to help me. Everyone in the street knows about 
my HIV but they laugh at me they say, “hey you talking nonsense... I go to them..I’m HIV 
positive, they don’t believe me, you go and seek boyfriends outside the door but your 
parents they look after you maybe you must listen to them”(Female, 38 yrs). 
  
The 38 years old female respondent publicly disclosed her HIV status in order to raise 
awareness in the community about HIV.  
 
  
 
 
 
 
 32
4.2 Barriers to Adherence 
4.2.1 Economic Barriers  
The economically related factors that obstructed the respondents from taking their ART as 
prescribed were: poverty and unemployment, lack money for transport, lack of food and 
disability grants.   
 
Poverty and unemployment 
Many respondents reported that they skipped taking their ART because they were poor and 
unemployed and therefore could not raise enough money to meet their other personal needs as 
well as to buy food to enable them feed properly so as to take their ART as prescribed.  
 
 “I don’t work, I’m not eating properly, I don’t have food, I don’t have money and those 
thing and the baby is…you see for me why would I drink the pills it doesn’t help me at 
the end of the day”(Female, 38 yrs). 
 
Lack money for transport 
A 63 years old female respondent said that, she missed her appointments with the ART clinic 
because she did not have money for transport; she further complained that the Vredenburg 
clinic was too far for her to pick up her medications. 
 
“There are sometimes that I will need to go to the clinic and have no money so I will 
ask for assistance from my children and sometimes when I have no money for transport 
I hike to the ART clinic” (Female, 60 yrs)  
 
It was reported that a taxi fare to go the ART clinic and return at the time of this study was R36. 
 
Lack of food  
A 53 year old female respondent complained that she did not take her ART for some days 
because she did not have any food to eat.  
 
“I’m not eating properly, I don’t have food, I don’t have money and those thing and the 
baby is…you see for me why would I drink the pills it doesn’t help me at the end of the 
day”(Female, 38 yrs). 
 
Disability grants  
It was reported that some patients deliberately discontinued taking their ART in order to 
became very sick and have their CD4 count drop to a very low level.  Such patients also 
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dishonestly told the doctors that they had no form of financially support so that the doctors 
could qualify them for a disability grant on the bases of their illness, low CD4 count and also 
due to the fact that they had no source of income or financial support.  
 
“Maybe you will qualify for a Grant which the doctor will see you don’t have an income 
and you can’t work, you are weak. So most of them, they just uh…Stop with the 
medication because they want to receive a Grant, (Female, 33 yrs).  
 
4.2.2 Social Barriers  
 Some socially related factors that hampered adherence to ART were: fear of unintended 
disclosure by using the ART clinic, fear of unintended disclosure when seen talking to 
community HIV care providers, fear of unintended disclosure leading to the clandestine buying 
of ART, stigma and discrimination, peer influence and the fear of being humiliated   by others 
if known to be HIV positive in the community.  
  
Fear of unintended disclosure of HIV status from using the ART clinic 
A small number of HIV positive patients were reported to have terminated the use of the ART 
clinic because they were afraid that their HIV status could be unintentionally disclosed to 
others if they were seen queuing up at the ART clinic regularly.  
 
“They don’t want to talk about it. They don’t want that other people to know they have 
HIV. Or maybe they don’t want it known or want to be seen”. (Female, 33 yrs) 
 
Fear of unintended disclosure of HIV status from talking to community HIV care providers  
It was noted that the community members used workers providing HIV care as markers of 
PLWHA in the community and as a result of this; if someone was seen having a lengthy 
discussion with any HIV care providers, that person’s HIV positive status was automatically 
assumed and this caused some patients to miss important appointments with HIV care 
providers.   
  
 “…So if they see someone from the community speaking with these ART workers for a long 
time, they assume that person speaking with them is HIV positive” (Female, 60 years)  
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Fear of unintended disclosure of HIV status leading to the clandestine buying and selling of 
ART 
It was reported that some patients in the community stopped going to the ART clinic because 
they did not want others to know about their HIV status. This group of patients was reported to 
have been going behind the healthcare providers and instigating other patients using the ART 
services to clandestinely steal some of their pills and sell the stolen pills to them.   
 
“I heard that other people saying maybe if, I’m working now and I have a friend who is 
HIV now that friend don’t want to come to the doctor then maybe I steal the tablets here 
and then I take it to her. I heard other people saying like that”. (Female, 33 yrs). 
 
Stigma and discrimination 
Some patients discontinued taking their ART and started drinking heavily in order to cope with 
the emotional depression that they developed from being stigmatized and discriminated against 
by their friends and some family members at home.  
 
“Okay? So some of my friends, they don’t worry about me, they ignore me or if I came 
to her she will say, “oh! I want to go there or there or something like that. So the 
experience was - some of the people don’t want you - because of the sick that you have, 
they don’t want to drink in your cups or eat out of your bowl. My mother was doing 
that, because I was having my own glass, my own cup and my own plate, it made me 
feel like I never wanted to live anymore. So! That is why I started drinking.” (Female, 
25 yrs).  
 
Peer influence 
A respondent reported that she took advantage of her improved health and deliberately 
terminated her ART because she wanted to carry on with her social life as she did prior to 
developing AIDS.  
 
 
“ I was not taking them, and the weekend I was not taking them. , because I was for a 
year and two months without, without my pills….It was on my birthday when I start 
drinking, July month” (Female, 25 yrs).  
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The use of the HIV status of PLWHA as a device to humiliate them  
A 32 years old female also reported that she discontinued taking her ART for 7 days because 
her boy friend used her HIV status to disgrace her openly.  
 
 
“I stopped taking my ART for about two weeks because my boyfriend humiliated me 
that, I was an HIV patient” (Female, 32 yrs).  
 
4.2.3 Health System Barriers  
Some of the health system related factors that negatively influenced adherence were: the lack of 
follow up of patients, dissatisfaction about the quality of ART services provided, lack of 
confidentiality in the way patients HIV results were handled, long waiting times in queues at ART 
clinics, the fear of picking up infections from other patients in the OPD and the fear of unintentional 
disclosure of HIV status as a result of the exposed location of the ART clinic in the hospital.   
 
Lack of follow up  
A respondent missed taking his ART due to the inadequate follow up on his ART treatment by 
the nurse in charge of him at the rehabilitation unit. As a result of this negligence of duty, his 
ART got finished without the nurse taking note of this thus he missed his pills for four days 
after which they were then replenished.   
 
“When I was leaving all the pills were finished. So I left, I was for 4 days, without it”… 
 (Male, 38 yrs)  
 
4.2.4 Therapy Related Barriers   
Two therapy related factors that hindered adherence to ART were side effects and feeling better 
after commencing with treatment.   
 
Side effects and discomfort  
Some respondents reported that they stopped taking their ART when they experienced side 
effects.  
 
“I said Doctor, I just stopped my pills for three weeks I got fed up of with these pills, 
you know what I’m saying and now I experienced the itching and all those things and 
I’m stressed out all those things”. (Female, 38 yrs). 
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The 38 years old female was the only respondent who stopped taking ART for three weeks 
because she got fed up with the itches she experienced when she started taking the treatment.  
 
Feeling better  
Some respondents terminated their ART when they started feeling better and wanted to carry 
on with their lives just in the same way as they did before they were placed on ART.  
 
“So at the time, when, the first time I got sick, I got really, really sick and I was taken to 
Siyabonga, I got strong and I was on my own, started drinking and smoking again and 
that is why I dropped my pills; and then I came again back to Siyabonga because I was 
sick,” (Female, 25 yrs) 
 
4.2.5 Patient Related Barriers 
The following patient related factors that negatively affected adherence were: alcohol abuse 
and smoking, emotional distress, forgetfulness, confusion, fatigue and hard labour. 
 
Alcohol abuse and smoking  
Alcohol is known to impair peoples reasoning and can therefore negatively affect adherence.  
Most respondents who started drinking heavily and smoking while on ART reported that, heavy 
drinking and smoking hindered them from taking their ART as prescribed. While those who 
drank heavily and smoked only occasionally during weekends and birth-day parties also 
reported that they missed taking their ART after drinking heavily.  
  
“I was on my own, started drinking and smoking again and that is why I dropped my 
pills and now I am back on treatment.” (Female, 25 yrs) 
 
Emotional distress  
Emotional distress can disrupt peoples’ modes to concentrate on taking their ART. According to 
some respondents they did not concentrate on taking their ART as prescribed because they were 
emotionally distressed by either broken relationships or by stigmatization and rejection at home.  
 
“Something that happened between us so; we were not married… So I decided to leave her 
alone. I couldn’t use that medication and I came to the doctor and I’m told him but-but this 
woman, what she has done to me I can’t take it any longer so I, I started drinking”…  
(Male, 38 yrs).   
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Forgetfulness 
Many respondents said that they missed taking their ART most of the times due to 
forgetfulness. A 38 years old male respondent explained that he missed taking his ART because 
he often forgot about them especially when he was overtaken by sleep and did not hear the 
alarm of his clock or phone.  
 
“You see that happened to me, not so, so far away from 7 o’clock, it happened once with 
me, say that; the morning 7 o’clock né? I drink my pills but at that time its 7 again…I 
forgot, but it was ‘to 8” (Male, 38 yrs).  
 
Confusion 
Some respondent mentioned that they did not take their ART accurately at the prescribed time 
because they were often confused and unable to recall exactly the time and the right number of 
pills to be taken. One respondent said that due to confusion on the accurate time and the 
number of pills to be taken, he sometimes took some pills later on or took more pills that the 
doctors prescribed in order to chat-up with the pills that he had missed the previous day.  
 
“Then I asked her ‘Sister hmm, why do you give me this one in the morning and this one 
in the afternoon, say when I am going to sleep?’ She said ‘I learnt that from the doctor 
that you must drink the 2 in the morning and when you go to sleep, say from between 
12.”(Male, 36 yrs) 
 
Fatigue and hard labour 
A male respondent reported that he skipped taking his ART at night before sleeping because he 
got too tired from working very hard during the day and was overtaken by sleep.  
 
“Wednesday, Thursday I’m working so hard, sometimes I come home  and sit down, 
and I fall asleep” (Male, 38 yrs).  
 
4.2.6 Cultural Barriers   
A culturally related factor that had a negative effect on adherence was the simultaneous use of 
concoctions from traditional healers and ART.   
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The simultaneous use of concoctions from traditional healers and ART  
The use of concoctions from traditional healers and ART simultaneously obstructed adherence 
as it was reported that some respondents were still using concoctions prepared by traditional 
healers for cleansing their bodies internally even though they were also taking ART.   
 
“No, no! I’m using the mixture, it’s the mixture that must make me like this, and it’s 
cleaning me.” That’s my concern. (Female 38 yrs). 
 
A 38 year old female respondent confirmed that she was of the opinion that one could take 
mixtures from traditional healers while on ART as long as one informed both the traditional 
healers and their doctors about the different medications they were using.   
 
“You have to take both of them, and you have to tell your traditional healer you are on 
ARV’s.....” (Female 38 yrs). 
 
4.3 Motivators and Facilitators of Adherence 
4.3.1 Social Motivators and Facilitators  
More socially related factors influenced adherence compared to others factors. The following 
are the socially related factors that were recorded to positively influence adherence: emotional 
and family support, disclosure, having children to look after, having spiritual support from the 
church, TV programmes, phone, radios and alarm clocks, belonging to an HIV support group 
and receiving words of encouragement from an intimate person.   
 
Emotional and family support  
Many respondents reported that they were motivated to continue taking their ART as 
prescribed from the emotional support that they received from their family and loved ones.  
 
“My brothers, they know, my mother knows, my father knows, they are all of them 
living.... They support me” (Male, 38 yrs). 
 
A number of respondents mentioned that even though they were not receiving any disability 
grants, they were able to use their partial disclosure to gain different forms of support from 
their family members and friends as well. 
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A female respondent narrated how she was able to receive moral support from her family 
members when she partially disclosed her HIV status to them.  
 
“ I said, no I did work and I did buy food but sometimes they come and check 
themselves and from there on you want to disclose to your family and friends so that 
you can be helped in getting stronger every day”...(Female, 38 yrs). 
 
Disclosure  
Disclosure of HIV status is a difficult process and is a fundamental step in accepting one’s HIV 
status and the readiness to live with the disease and therefore a good predictor of adherence to 
treatment.   
 
“…I just put all my pills in my bag and I don’t worry about which tablets, whoever sees 
me taking out there, “what are you doing, I’m taking my pills I’m HIV positive, hey 
uyageza wena!” Ngithi, yeah, its fine and I take my pills and drink.”... (Female, 38 yrs).    
 
A 38 years old female respondent reported that when she fully disclosed her HIV status to 
people in the community, it enabled her to take her ART anywhere and at any time without the 
fear of stigma. 
 
Having children to take care of  
Many mothers reported that they were inspired to adhere to their ART despite the challenges 
they were going through while taking the treatment because they had children to take care of. 
 
“I am really glad that I am here at Siyabonga so that I can get my life back on track and for 
my child’s sake - so I am gonna take my treatment, so that I can live longer. Wasn’t it for 
my child then I wasn’t gonna worry on, gonna take my pills again or something like that. So 
it is only for my child that I do it”… (Female, 25 yrs). 
 
Spiritual support from the church  
A good number of respondents reported that they drew their inspiration to continue taking their 
ART from constantly reading their bibles and fellowshipping with other Christians and also 
from the prayer sessions that were organized at different homes by their pastors.   
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“I use my Christianity with my doctor and I take what I get in the hospital and go and 
tell my Reverend or some, or somebody at my church I-I know I have to communicate 
with. Then the side effect of the treatment, everything, I have to communicate with; I 
have to take my Christianity and my, my medication and my doctor and put them 
together”… (Female, 38 yrs). 
 
TV programmes, phones, radios and clock alarms 
A patient reported that he used articles such as radios, alarm clocks and TV programmes like 
7delaan as reminders to enable him remember when to take his ART.   
 
 “Yes I have my phone, I have that small radio clock .......and I know but at that time for 
7de Laan then I’m taking my pills. It is only that 3 then I’m holding it in my hands and 
when 7de Laan is finished, I just run into the kitchen and/or ask the guy ‘can you just 
get me a glass of water... (Male, 38 yrs).   
 
 Belonging to an HIV support group 
 A fifty-one year old male respondent mentioned that, the Mfesane support group that he was 
told by his home based care giver to join was supporting him with food, vegetables and other 
things to do which were helping him to adhere to the treatment.  
 
“The support group is fine they give me food, vegetables and things to do”,   
(Male, 51 yrs).  
 
4.3.2 Health System Related Motivators and Facilitators  
Four health system related factors that influenced adherence positively are: sharing experiences 
and difficulties with other patients, good service delivery by the healthcare providers, believing 
in the treatment and good treatment literacy; and the use of pill boxes.   
 
Sharing experiences and difficulties with other AIDS patients 
Most respondents reported that at first they did not know how to accept their HIV status but 
after constantly sharing some experiences and difficulties with other patients at the ART clinic, 
they were encouraged to stay focused on taking their ART as prescribed. 
 
“As I, I, I come here to the ARV clinic I don’t see why people should stop their 
medication because we, as we sit there we name that ‘our place of school’ because 
there we share and we talk, we talk our problems and we share our problems and 
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sometimes - and also the workers at our/the ARV clinic - we don’t feel nervous or what 
or what”... (Female, 38 yrs).  
 
Good service delivery from the healthcare providers 
Many respondents reported that the good services that they were receiving from their doctors, 
nurses, pharmacists and counselors gave them new strength to continue with their ART. 
 
“I see it as a good system because last time I visited Eastern Cape, I was at one of the 
Eastern Cape hospital, I can’t remember/name the hospital now… uh. As I sat there and 
saw how they treat their patients. I said, I can, I can clap hands for the Western Cape”. 
(Female, 38 yrs).  
 
Believing in the treatment and good treatment literacy  
Many respondents said that they were encouraged to take their ART because they believed that 
if they continued taking them as the health care providers told them to do, their CD4 counts 
were going improve and they will get well again and their lives will be prolonged as well.   
 
 “What I believe is what I get in and what I believe in and what I think is that you have 
to continue with your medication” (Female, 38 yrs). 
 
Pill Boxes  
One female respondent reported that the pills boxes that she was using made it easier for her to 
take her ART at night and in the morning without any difficulty.  
 
“Yeah it’s easy now in this pill box cause I’m already taking the pills during the night 
you see, and then this morning I just take out in the bag, get myself ready put it straight 
and then go and I’m back out there”… (Female, 38 yrs).   
 
4.3.3 Patient and Therapy Related Motivators and Facilitators 
The patient and therapy related factors that motivated and positively influenced adherence 
were: the hope to live longer, the fear of the deadly consequences of poor adherence from 
patients using traditional mixtures, learning from the past experiences of poor adheres and 
feeling better after commencing with treatment.  
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The hope to live longer  
Many respondents reported that even though they knew that the ART was not going to heal 
their HIV positive status completely, they were still encouraged to continue taking them 
because they nursed the hope that the treatment will prolong their lives.  
 
“I am really glad that I am here at Siyabonga because that I can get my life back on 
track and for my child’s sake - so I am gonna take my treatment, that I can live 
longer” (Female, 25 yrs).  
 
The fear of the deadly consequences of poor adherence from patients using traditional mixtures   
Most respondents said that they were inspired to continue taking their ART because they knew 
some friends in the community who died shortly after abandoning their ART for mixtures from 
traditional healers.   
 
“I saw people going to the healers outside there but end of the day they are 
underground you see, they are dying outside there because  they are believing in the 
healers outside there and they  are not taking the pills”… (Female, 38 yrs).  
 
Learning from the past experiences of poor adherence  
Many respondents reported that they were inspired to adhere to their ART because when they 
stopped taking them for a short time they got very sick again and started developing the AIDS-
like symptoms which they did not want to experience again. 
   
I got sick, I got really, really sick and I was taken to Siyabonga, I got strong and I was 
on my own, started drinking and smoking again and that is why I dropped my pills; and 
then I came again back to Siyabonga because I was sick again” (Female, 25 yrs).  
 
Feeling better  
A majority of the respondents reported that they were motivated to adhere to their ART 
because they regained their health when they started taking them and the AIDS-like symptoms 
that they had developed when they were very sick disappeared.  
 
“The ARVs works well when one takes it regular, you need to take it regular ‘cause 
there was a time when I wasn’t doing it regularly then I get some rash on my skin, skin 
rash and so on; my tongue was sore and all those things”… (Female, 38 yrs) 
 
 
 
 
 
 43
4.3.4 Economic Motivators and Facilitators  
The following economic factors that were found to have motivated and facilitated adherence 
were: disability grants and being employed.  
 
Disability grants  
Some respondents confirmed that the disability grant that they were receiving helped them to 
buy basic needs and settle bills and thus relieved them of some financial constrains and also 
facilitated them to focus on taking their ART properly.  
 
“It’s a small Grant because it’s not a normal Grant. It’s uh, it’s something minimal 
No I’m not working now; I’m looking for a job now” (Female, 38 yrs) 
 
Employment  
A female respondent reported that the money she earned from her counseling job enabled her to 
take care of her family responsibilities and to focus more on taking their ART as prescribed.  
   
       “No, Edcon is just a private company they brought us on the umbrella of Jet stores and 
        CNA and working with Edgars, I’m paid by Edcon in Edgars in the mall” 
      (Female, 38 yrs). 
 
Summary 
In this chapter data was analyzed and factors that negatively influenced adherence identified as: 
awareness of HIV status, disclosure, unemployment, lack of transport, insufficient feeding, 
disability grants, alcohol and illicit trade in ART, alternative forms of therapy and stigma. It 
was also noted that, inadequate follow up, recklessness in the way patients’ HIV results were 
handled, long waiting times and the fear of picking up other types of infections from other 
patients in the OPD also came under major criticisms from patients. Finally, the sharing of 
experiences at the clinic visits, good healthcare provider-patient relationships, believing in the 
treatment, good treatment literacy, being a parent and having children to look after, the use of 
pill boxes, social and spiritual support from family members, friends and loved ones were also 
identified as  factors that positively influenced adherence.  
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CHAPTER FIVE 
 
DISCUSSION 
 
Introduction 
This final chapter will focus on discussion, conclusion and recommendations as well as the 
strengths and limitations of the study. The first part of the chapter examines the findings 
obtained on awareness, acceptance and disclosure of the HIV status of the participants and is 
closely followed by the next section that explores other factors that influenced adherence. The 
results of the study are discussed along the themes and categories that were derived from the 
data and where necessary, citations are used to substantiate relevant results. The chapter is 
concluded with recommendations and the strengths and limitations of the study.  
 
Awareness and acceptance of HIV diagnosis  
Awareness of HIV status was found to be an important predictor of poor adherence.  Our 
results revealed that, those respondents, who became aware of their HIV status through 
conditions of protracted illnesses or providers initiated HIV testing, adhered poorly to therapy 
while those who became aware of their HIV status through VCT, had a better adherence. 
Acceptance of one’s HIV status was found to be the rate determining step towards one’s 
dedication to taking the ART as prescribed. Those participants who easily accepted their HIV 
status were found to be more committed to taking their ART and thus showed a better 
adherence to therapy compared to those who took a longer time to accept their HIV status. 
These finding are similar to those obtained from studies in Cote d’ Ivoire, the Republic of 
South Africa and the United States of America that acceptance of HIV diagnosis and the 
commitment  to taking one’s ART  were vitals steps towards good adherence (Eholie et al., 
2007; Gilbert et al., 2009; Godin et al., 2005).   
 
Poverty 
Financial constraints as unemployment, lack of transport and food insecurity were found to obstruct 
adherence. This is consistent with literature that patients on higher incomes have less difficulty with 
adherence compared to patients with low income levels (Pratt et al., 1998). In our study, many 
respondents missed hospital appointments and or their doses either because they were unable to 
raise enough money for transport or because they were unable to buy food and feed properly to 
enable them take the medications as prescribed. These finding are  also in line with many adherence 
studies in Africa and other parts of the world which have already reported unemployment, lack of 
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transport and insufficient feeding as factors negatively impacting on adherence (WHO, 2006; 
WHO, 2010). Even though ART programmes are presently making them more affordable to ART 
users by providing them free of charge at the points of delivery, unemployment, transportation cost, 
child care, school fees, and lack of food as well as loss of earnings are still major concerns to 
adherence in many resource limited countries (Weidle et al., 2002).   
 
Disability grants  
Disability grants were of a particular importance in this study, for the reason that, it had a 
positive and a negative influenced on adherence. For instance, some ART users in the study 
were reported to have discontinued taking their therapy in order to get very sick, keep their T-
cells count below the 200 limit so as to meet some of the requirements needed for the grants or 
to regain the grants.  It has been previously reported that, in South Africa the loss of the 
disability grant as a result of improved health, has a significant impact on the physical and 
emotional health of PLWHA, as this leads to high levels of stress on PLWHA because healthy 
diets may no longer be accessible and this could in turn undermine their adherence (De Paoli & 
Mills, 2010). However, contrary to this, our study found that, the disability grant also assisted 
some participants to settle bills, buy food and address other personal and family problems 
enabling them to focus more on taking their ARVs correctly.  
   
Disclosure of HIV status  
Disclosure of HIV status was found to be very fundamental in HIV care. Disclosure of one’s 
HIV status was a difficult process and a primary step in accepting one’s HIV status and the 
readiness to live with the disease. A number of patients in our study skipped their doses or 
missed hospital appointments because they were afraid that, their HIV status could 
unintentionally be disclosed if they were seen in queues at the ART clinics regularly. These 
findings are common to those obtained in an Ethiopian study where patients who did not 
disclosed their HIV-positive status traveled long distances to obtain anonymous treatment, hid 
or skipped pills to ensure that families’ members and employers did not know about their status 
(Mekonnen et al., 2010). Nonetheless, disclosure was also found to play a positive role in 
adherence given that those patients who intentionally disclosed to family members, friends or 
religious groups, gained some form of social, physiological, economical and spiritual support 
which motivated them to step up their adherence.   
 
It has been noted that various forms of social support from family and friends to PLWHA can 
influence their behavior and decisions regarding treatment (Roura et al., 2009). Individuals can 
develop a willingness to sustain adherence in a challenging context but are more likely to do so 
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within supportive family and community environments (Roura et al., 2009). A South African 
study also found that social support was instrumental in helping ART patients to achieving 
compliance beyond the first three months of treatment (Nachega et al., 2006; Roura et al., 
2009). 
 
Stigma and emotional distress 
 Stigma was found to be pivotal in steering up discrimination against people living with AIDS 
in the community and thus negatively influenced adherence in our study. Stigma and 
discrimination have been reported as two important variables greatly contributing to the low 
uptake of VCT, disclosure, and poor adherence to ART (Kagee & Delport, 2010). In this study, 
stigma was found to have provoked discrimination, rejection and the isolation of PLWHA. This 
poor treatment created the emotional distress that pushed some patients to skip doses and to 
take up heavy drinking as a way of comfort. These findings are comparable to those obtained 
by Moore and Graham (1997) and Nachega et al. (2006) where stigma and discrimination was 
found to have negatively influenced adherence by subjecting ART users to heavy alcohol 
consumption which made them to forget taking their doses as prescribed. 
 
Inadequate follow up and dissatisfaction in ART services 
In a study from Tanzania, long waiting hours and the spending of over ten hours in a hospital 
setting to access ART care was reported to reduce clinic attendance and consequently hindered 
adherence (WHO, 2006).  Inadequate follow ups on some patients, the lack of confidentiality in 
the way HIV results were handled,  long waiting times in queues at ART clinic as well as  the  
fear of picking up other infections from other patients in the OPD, were reported as major 
concerns in this study. These concerns require special attention as they may in the long run 
negatively influence adherence. On the other hand we found that, the sharing of experiences at 
the clinic visits, good healthcare provider’s patient relationships, believing in the treatment, 
good treatment literacy and the use of pill boxes positively influenced adherence.  
 
Side effects and discomfort  
While therapy related variables such as the complex nature of antiretroviral regimens, high 
number of pills, foods and fluids restrictions as well as the difficulty of fitting regimens into 
daily living activities were reported by Ammassariet et al. (2002) to negatively influence 
adherence, the same variables did not seem to have an effect on adherence as reported by 
Deschamps et al. (2004).  However, in our study only one of respondent reported that she 
stopped taking her medications for two weeks because of the unbearable itches that she 
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experienced. Our findings are comparable to the results obtained from a majority of other 
studies from Africa, which did not find any association between pill burden and the side effects 
of taking ARVs as a major barrier to adherence (Gilbert and Wlker, 2009). Even though the 
adverse side effects of taking antiretroviral medications have been reported to hinder adherence 
in studies from South Africa, Nigeria and the USA, Malangu (2008) and Uzochukwa et al. 
(2009), the hazardous practical experiences of living with untreated HIV/AIDS experienced in 
Sub-Saharan Africa, have been suggested to be the driving force behind the better adherence 
results reported in these African adherence studies (Nachega et al., 2005; Weiser et al., 2003).  
                                                                              
Feeling better and the hope to live longer 
Feeling better in this study was like a double edged sword which positively and negatively 
influenced adherence in some patients. While some ART users believed in the treatment 
because they were sure to regain their health, others took advantage of their improved health 
and deliberately terminated their ART in order to carry on with their past risky social life 
styles. Outstandingly, the hope to live longer and the disastrous experience of some poorly 
adhering patients was found to have motivated good adherence in some patients. Nonetheless, 
having children to look after was found to be a great motivator of good adherence to the female 
patients than to the male patients. The hoped that ART was going to enable some patients to 
regain their health and continue to work in order to support their families financially was also a 
good motivator of adherence in both male and female respondents. This results matches those 
obtained by Watt et al. (2009) that men were motivated to adhere to treatment because it 
provided them with an opportunity to return to their work, support their families, and care for 
their children. Even though in this study, more women than men expressed children as a 
motivator of good adherence, the fact that good adherence could give them a chance to 
continue to work and support their families, motivated both male and female patients equally to 
adhere to the treatment. The same study revealed that women have set schedules, often bound 
to responsibilities of the home, which make it easier to incorporate pill-taking in their daily 
schedules (Watt et al., 2009). 
 
Substance abuse, forgetfulness and fatigue  
Heavy alcohol consumption which is well known to impair judgment, affect concentration, 
memory and motivation was found to negatively influence adherence in this study. These 
findings corroborates to published reports in a study of 1889 HIV clients on ART medications 
which showed that non-adherence was linked to heavy alcohol drinking (Tucker et al., 2004). 
In this study, we also found that most of our respondents who started drinking heavily and 
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smoking while on ART reported that, heavy drinking and smoking hindered them from taking 
their ART as prescribed.  Substance abuse in patients taking ART have been noted to have  far 
reaching consequences on their ability to adhere to therapy, as it makes it difficult for them to 
receive any form of social and family support which can motivate them to  adhere properly to 
therapy (Kagee, 2004). Although alcohol and smoking were found to negatively influence 
adherence, other factors associated with substance abuse such as forgetfulness, fatigue and 
confusion were also recorded to have negatively influenced it.   
 
 The use of alternative therapy 
The use of traditional medicines while on ART has been previously reported as a potential 
barrier to adherence (Dahab et al., 2008). In this study, many respondents on ART were 
reported to have been using concoctions prepared by traditional healers for cleansing their 
bodies and others were of a strong opinion that, one could take mixtures from traditional 
healers while on ART, if one informed both parties. This suggests that, the concomitant use of 
traditional mixtures while on ART could be a barrier to adherence in the community. Fears of 
compromising adherence by the activities of traditional healers and religious prophets  leading 
to the concomitant use of ARV medication and traditional medicines, or causing patients  to 
switch from one form of treatment to another have long been reported (Nyika, 2007). In Van 
Dyk (2001), it was reported that people in several African communities believed that HIV was 
transmitted by witchcraft and as a result of this belief, visit traditional healers for solutions to 
their health problems. On the contrary, this believe did not influence our respondents’ choice of 
therapy and none of them associated their HIV status to witch craft. It is worth mentioning that 
some respondents were still visiting traditional healers and religious prophets for prayers and 
other solutions to their HIV problems. The findings from this study are parallel to those in 
Zouet al. (2009), that a greater fraction of Pentecostal church members than Catholic or 
Lutheran church members believed that prayers and holy water only, could cure HIV/ AIDS 
with some Christians admitting that they would refuse ART in preference to prayers and holy 
water from their pastors for a cure to their HIV/AIDS.  More investigations are required to give 
us a more accurate data on the scale of the use of alternative therapy in Vredenburg for the cure 
of HIV.  
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CHAPTER SIX 
 
CONCLUSIONS AND RECOMMENDATIONS  
 
This study sought to explore barriers to adherence to antiretroviral among patients in a regional 
hospital in Vredenburg, Western Cape. The explorative study conducted on patients accessing 
ART from the Vredenburg hospital thus reveals the intricacy of adherence vis-à-vis the barriers 
patients in Vredenburg face in their attempts to access and adhere to ART. This study identified 
financial constraints as a major factor that obstructs adherence in Vredenburg. Although ART 
are provided free of charge at the points of delivery, transportation cost, child care, school fees, 
lack of food, loss of earnings as well as unemployment are still reported as obstacles to 
adherence. It worth mentioning that many patients missed hospital appointments and or their 
doses either because they were unable to raise enough money for transport or because they 
were unable to buy food and feed properly to enable them take the medications as prescribed by 
the doctors. Other studies have already reported financial constraints linked to unemployment, 
lack of transport and insufficient feeding as factors negatively impacting on adherence in other 
parts of Africa (WHO, 2006).   
 
Inadequate follow ups on patients, confidentiality in the way patient’s HIV results were 
handled, long waiting times in queues at the ART clinic as well as the fear of picking up 
infections from other patients in the OPD came under major criticisms from patients. On the 
other hand, the sharing of experiences at the clinic visits, good healthcare provider patient 
relationships, being a parent and having children to look after, believing in the treatment, good 
treatment literacy and the use of pill boxes also significantly influenced adherence positively.  
 
This study further identified that, patients in Vredenburg were still facing significant barriers 
surrounding stigma; as stigma and discrimination greatly contributed to the low uptake of VCT 
and disclosure. Disclosure of one’s HIV status was a difficult process and a fundamental step in 
accepting one’s HIV status and the readiness to live with the disease. As such a number of 
patients skipped their doses or missed hospital appointments because they were afraid that their 
HIV status could unintentionally be disclosed if they were seen in queues at the ART clinics 
regularly. Stigma was also found to have provoked discrimination in some people, causing 
them to reject and isolate people living with AIDS in the community. The rejection and 
isolation experienced by people living with AIDS as a result of their status, emotionally 
distressed them and made some patients to develop depressions which caused them to skip 
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doses or to the take up heavy drinking as a way out of the HIV burden. Many patients in the 
study also feared that they would lose support from their loved ones, marriages, and their jobs 
based on peoples perspectives surrounding HIV/AIDS in the community.  
 
Finally, even though barriers such as financial constraints, substance abuse, alternative therapy 
disclosure and recklessness in healthcare services obstructed adherence in this study, 
HIV/AIDS has been a stigmatized illness since its onset in the early 1980s and, these results 
highlight that such stigma has yet to dissipate in Vredenburg. Therefore, stigma and disclosure 
must remain at the forefront of the ART programme implementation in Vredenburg, while long 
term projects that can support ART users economically should be created through partnerships 
with non-governmental organizations and the government of South Africa to optimize 
adherence in the Vredenburg.   
 
Recommendations 
After an in-depth exploration of the barriers faced by people PLWHA in their everyday 
attempts to adhere to HIV treatment, the following recommendations have been made to assist 
the community members, healthcare providers, ART users, policymakers and programme 
managers to take the necessary steps that will support and maintain good adherence in the 
community. 
 
Community members 
• To show love and respect to people living with HIV/AIDS in the community.  
• To provide more supportive home based environments to HIV/AIDS clients at all times.   
• To build up better collaborations between traditional healers, religious prophets and 
healthcare providers in sensitizing the community on HIV/AIDS and to plan strategies 
to improve adherence.  
• To organize and intensity community sensitizations on HIV/AIDS addressing stigma 
and discrimination.  
• To create long term projects that will support ART users economically for as long as 
possible through partnerships with non-governmental organizations and the government 
of the Republic of South Africa.   
• To carry out further studies that will give a more accurate data on the scale of the use of 
alternative therapy in Vredenburg for the cure of HIV/AIDS.  
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Healthcare providers  
• To serve and treat their clients with love and respect.  
• To decentralize ART health services and provide them at a community based level. 
• To extend their opening hours and also to provide ART services on public holidays. 
• To provide ART services in a convenient environment that would not lead to the 
unintentional disclosure of the HIV status of their clients to other patients in the 
health facility. 
• To intensify follow ups on ART users who have defaulted due to one reason or 
another.  
• To develop checklists, reminder cards and the sending of short messages via mobile 
phones to help ART users not to forget taking their pills as prescribed.  
• To conduct further studies to determine the magnitude and factors influencing the 
illicit trade in ART in the community.  
• To intensify research on a possible vaccine or cure of HIV/AIDS.  
 
ART users 
• To fully disclosed their HIV status in order to disperse the stigma attached to 
HIV/AIDS in Vredenburg.   
• To put into action the lessons they are taught in their support groups meetings and to 
share their difficulties as well as experiences with other patients and the healthcare 
providers.   
• To build enough confidence to speak to the community members about HIV/AIDS, 
treatment adherence, and gender issues, such as men‘s ability to support their female 
partners in treatment.  
• To trust their healthcare providers and belief in the therapy which they are using.  
 
Policy makers 
• To promote and improve legislation surrounding poverty and the employment of people 
living with HIV/AIDS.  
• To promote and implement legislation that would lead to the reduction of stigma and 
discrimination against PLWHA in the Vredenburg.  
• To educate PLWHA on their rights in Vredenburg.  
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ART programme planners   
• To build the capacity of PLWHA to initiate awareness-raising and educational activities 
related to issues of stigma and discrimination in the community. 
• To intensity sensitizations on HIV testing reluctance, disclose of positive status and the 
acceptance of HIV status.  
• To develop and implement policies that will decentralize ART health services and make 
them more community based.   
 
Strengths and Limitations of the Study  
The principal aim of this qualitative study was not to generalize the findings to a larger 
population as is the case with quantitative studies, but to elicit insights to develop action that is 
sensitive to local circumstances. However, barriers to adherence to antiretroviral medications 
among patients in a regional hospital in Vredenburg were what this study was interested in. 
Given that these barriers are not easily revealed by traditional epidemiological methods, we 
used in-depth interviews to gather the desired data for the study.  
 
Strengths of the study 
 This study like other qualitative studies has strengths worthy of mentioning. The following are 
some of the strengths of the study:  a purposeful sampling technique was used which ensured 
that a rich variety of cases of poor adherers in the ART programme of the Vredenburg 
provincial hospital were all well represented. Good eligibility criteria were used to exclude 
those patients who were not physical and mentally fit for in-depth interviews or patients who 
could not be reached by any means as well as those patients who were still on the wellness 
programmes. A sample of 18 information rich patients was purposefully drawn from those 
patients who meet the eligibility criteria including both male and female cases to avoid gender 
bias in the results. The interviews were audio–taped, conducted in the language of the 
participants’ choice and at a place of their convenience which encouraged them to talk freely 
about their feelings, illnesses and other experiences.   
 
Limitations of the Study 
The limitations of the study included the following:  data was not collected from some key 
informants as clinicians, nurses, health surveillance assistants (HSAs) and pharmacy 
technicians, traditional healers and religious prophets which could have also had an influence 
on the quality of the data.   
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There was also not enough time and financial resources to allow the researcher to personally 
monitor how all the interviews were conducted and this could also have had an influence on the 
quality of the data as well as the results that we have obtained from this study.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 54
REFERENCES 
 
 
Aadil, N., Houti, I.E. & Mousasamih, S. (2004). Clinical Review. Drug intake during Ramadan. 
British Medical Journal, 329, 778-782. 
Ammassari, A., Trotta, M, P., Murri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., 
D’Arminio Monforte A., Wu AW, Antinori A. (2002). Correlates and predictors of adherence 
to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic 
Syndr, 31, 123–127.  
 
Bangsberg, D. R., Charlebois, E. D. & Grant, R. M. et al. (2003). High levels of adherence do 
not prevent accumulation of HIV drug resistance mutations. AIDS, 17, 1925–32. 
 
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M. & Zolopa, A. R. et 
al. (2001).  Non-adherence to highly active antiretroviral therapy predicts progression to 
AIDS. AIDS, 15, 1181–1183.  
 
Beals, K. P., Wight, R. G., Aneshensel, C, S., Murphy, D. A. & Miller-Martinez, D. (2006). 
The role of family caregivers in HIV mediation adherence. AIDS Care, 18, 589-596. 
 
Beyene, K. A., Gedif, T., Gebre-Mariam, T. & Engidawork, E. (2009). Highly Active 
Antiretroviral Therapy Adherence and its Determinants in Selected Hospitals from South and 
Central Ethiopia. Pharmacoepidemiology and Drug Safety, 18, 1007-1015.  
Breier, M. (2007). The shortage of medical doctors in South Africa. Case study report forming 
part of the HSRC study: A multiple source identification and verification of scarce and critical 
skills in the South African labour market.  Cape Town HSRC press.  
 
Bukusuba, J., Kikafunda, J. K. & Whitehead, R. G. (2007). Food Security Status in 
Households of People Living With HIV/AIDS (PLWHA) in Uganda Urban Setting. 
British Journal of Nutrition, 98, 211 – 217. 
 
Burrage, J. & Demi, A. (2003). Buddy programmes for people infected with HIV. AIDS care, 
14, 52-62. 
 
 
 
 
 
 55
Carpenter, C. C., Cooper, D. A. & Fischl, M. A. et al. (2000). Antiretroviral therapy in adults: 
updated recommendations of the International AIDS Society-USA Panel. JAMA, 283, 381-90. 
Chesney, M. (2003). Adherence to HAART Regimens. AIDS Patient Care & STDs, 17, 169-
177.  
 
Chesney, M. A., Ickovics, J. R. & Chambers, D. B. et al. (2000). Self-reported adherence to 
antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence 
Instruments. Patient Care Committee & Adherence Working Group of the Outcomes 
Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255-66.  
 
Chi-Tai, F., Hsu-Mei, H., Mao-Yen, C., Yu-Yin, C., Jing-Shiang, H., Jung-Der, W. & Che-
Yen, C. (2004). Decreased HIV Transmission after a Policy of Providing Free Access to Highly 
Active Antiretroviral Therapy in Taiwan. The Journal of Infectious Diseases, 190, 879–885. 
 
Dahab, M., Charalambous, S., Hamilton, R., Fielding, K., Kielmann, K., Churchyard, G. J. & 
Grant, A. D. (2008). That is why I stopped the ART: patients' & providers' perspectives on 
barriers to and enablers of HIV treatment adherence in a South African workplace programme. 
BMC Public Health, 863-68.  
 
Denzin, N. K. & Lincoln Y. S. (1994) Handbook of qualitative research, pp.1-17. Thousand 
Oaks, California: Sage Publications.  
 
Deschamps, A, E., Graeve, V. D., van Wijngaerden, E., De Saar, V., Vandamme, A, M. & van 
Vaerenbergh, K. et al. (2004). Prevalence and correlates of non-adherence to antiretroviral 
therapy in a population of HIV patients using Medication Event Monitoring System. AIDS 
Care, 18, 644-657.  
 
Dhalla, S., Chan, K. J., Montaner, J. S. & Hogg, R. S. (2006). : Complementary and alternative 
medicine use in British Columbia – a survey of HIV positive people on antiretroviral therapy.  
Complement Ther Clin Pract, 12, 242-248.  
 
Dilger, H. (2007). Healing the wounds of modernity: Salvation, community and care in a Neo-
Pentecostal church in Dar Es Salaam, Tanzania. J Relig Af, 37 59-83.  
Donovan, J. L. & Blake, D. R. (1992). Patient non-compliance: Deviance or reasoned decision-
making? Soc Sci Med, 34, 507–513.  
 
 
 
 
 56
Dwyer, J. T., Salvato-Schille, A. M., Coulston, A., Casey, V. A., Cooper, W. C., Selles, W. D. 
(1995). The use of unconventional remedies among HIV-positive men living in California. 
AIDS Care, 6, 17-28.  
 
Eholie, S.P., Tanon, A., Polneau, S., Ouiminga, M., Djadji, A., Kangah-Koffi, C., Diakite, N., 
Anglaret, X., Kakou, A. & Bissagnene, E. (2007). Field Adherence to Highly Active Antiretroviral 
Therapy in HIV-infected Adults in Abidjan, Cote D’Ivoire. Journal of Acquired Immune 
Deficiency Syndromes, 45, 355-358. [Online] Available: http://www.ncbi.nlm.nih.gov/html 
[Downloaded 22/04/2010 09:30 PM] 
  
Farmer, P., F. Léandre, J. S.,  Mukherjee, M. S.,  Claude, P.,  Nevil, M. C.,  Smith-Fawzi, S. P.,  
Koenig, A.,  Castro, M. C., Becerra,  J., Sachs, A., Attaran, & Kim,  J. Y. (2001). Community-
based treatment of advanced HIV disease: introducing DOTHAART. Bulletin of the World 
Health Organization, 79, 1145-5.   
 
Fogarty, L., Roter, D. L., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient 
adherence to HIV medication regimens: A review of published and abstract reports. Patient 
Education and Counseling, 46, 93-108. 
 
Gilbert, L. & Walker, L. (2009). “They (ARV’s) are my Life, without them I’m Nothing”- 
Experiences of Patients Attending a HIV/AIDS Clinic in Johannesburg, South Africa. Health & 
Place, 15, 1123-1129.  
Godin, G., Cote, J., Naccache, H., Lambert, L. D. & Trottier, S. (2005). Prediction of adherence 
to antiretroviral therapy: a one-year longitudinal study. AIDS Care, 17, 493-504. 
 
Gray, F., Chrétien, F., Vallat-Decouvelaere, A.V. & Scaravilli, F. (2003). The changing pattern 
of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol, 62, 429-40. 
 
Gross, R., Bilker, W. Friedman, H. & Strom B. (2001). Effect of adherence to newly initiated 
antiretroviral therapy on plasma viral load. Acquired Immune Deficiency syndrome (AIDS), 15, 
2109-2117.  
 
Hardon, A., Davey, S., Gerrits, T., Hodgkin, C., Irunde, H., Kgatlwane, J., Kinsman, J., 
Nakiyemba, A & Laing, R. (2006): From access to adherence: the challenges of antiretroviral 
treatment. Studies from Botswana, Tanzania and Uganda. Geneva. 
 
 
 
 
 
 57
 
 
 
 
Hardy, W. D. (2003) New Strategies: Optimizing Antiretroviral Therapy for Treatment-
experienced Patients. Clinical Care Options, 19, 658–665.  
 
Heyer, A. & Ogunbanjo, G. A. (2006). A review of factors that influence adherence. SA Fam 
Pract, 48, 5-9. 
 
Hill, Z., Kendall, C. & Fernandez, M. (2003). Patterns of Adherence to Antiretrovirals: Why 
Adherence Has No Single Measure. AIDS Patient Care and STD’s, 17, 519-525.   
Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J., O'Shaughnessy, M. V. &  Schechter, M.T., et 
al. (1998). Improved survival among HIV-infected individuals following initiation of 
antiretroviral therapy. JAMA, 279, 450-454. 
 
Holmes, W. C., Bilker, W. B., Wang, H., Chapman, J. & Gross, R. (2007). HIV/AIDS –specific 
Quality of life and adherence to antiretroviral therapy over time. Journal of Acquired immune 
deficiency syndrome, 46, 323-327. 
 
Hope, R. & Israel E, (2007). The essentials of antiretroviral therapy for health care and 
program managers. Pathfunder international, Technical Guidance series number 5. Watertown 
MA: Pathfinder international.   
 
Ickovics, J. R. & Meisler, A. W. (1997). Adherence in AIDS clinical trials: a framework for 
clinical research and clinical care.  Journal of Clinical Epidemiology, 50, 385–391. 
Ickovics, J. R., Meade, C. S. (2002). Adherence to HAART among Patients with HIV: 
Breakthroughs and Barriers. AIDS Care, 14, 309-318. 
Kagee, A. & Delport, T. (2010). Barriers to Adherence to Antiretroviral Treatment. Journal of 
Health Psychology, 15(7), 1001-1011. 
Kagee, A. (2004). Adherence to antiretroviral therapy in the context of the national roll-out in 
South Africa: Defining a research agenda for psychology. South African Journal of Psychology, 
38, 413- 428.  
 
 
 
 
 58
Kagee, A., Le Roux, M. & Dick, J. (2007).Treatment adherence among primary care patients in 
a historically disadvantaged community in South Africa. Journal of Health Psychology, 12, 
444-460. 
 
Kelly, J. & Devers., R. M. F. (2000). Study Design in Qualitative Research – 2 Sampling and 
Data collection Strategies Education for health, 13, 2, 263-271. 
 
Korpela, M., Del la Harpe, R. & Luukkonen, I. (2008) Proceeding of SIG Glob Dev’s Annual 
Workshop, Paris France December 13.  
 
Kumar, R. (2005). Research methodology: A-step by –step guide for beginners (2
nd
 ed.). 
London: Sage.  
 
Larkin, M. (1998). Global Aspects of Health and Health Policy in Third World 
Countries. In Kiely, R. & Marfleet, P. (eds). Globalisation and the Third world. 
London: Routledge.  
 
Ledergerber, B., Egger, M., Opravil. M., Telenti, A., Hirschel, B., Battegay, M., Vernazza, P., 
Sudre, P., Flepp, M., Furrer, H., Francioli, P. & Weber, R. (1999). Clinical progression and 
virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective 
cohort study. Swiss Cohort Study. Lancet, 353, 863–868.  
 
Lévy, A., Laska, F., Abelhauser, A., Delfraissy, J. F., Goujard, C., Boué, F. & Dormont, J. 
(1999). Disclosure of HIV Seropositivity. Journal of Clinical Psychology, 55, 1041-1043. 
Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage 
Publications, Inc. 
 
Lyon, M. E., Trexler, C., Akpan-Townsend, C., Pao, M., Selden, K., Fletcher, J., Addlestone, I. 
C. & D’Angelo, L. J. (2003).  Family group approach to increasing adherence to Therapy in 
HIV-Infected Youths: Results of a pilot project. AIDS Patient and STD’s, 17, 299-308.  
 
Maggiolo, F., Maggiolo, F. & Ripamonti, D, et al. (2003). Once-a-day therapy for HIV 
infection: a controlled, randomized study in antiretroviral-naive HIV-1-infected patients. 
Antivir Ther, 8, 339-46. 
 
Malangu, N.G. (2008). Self-Reported Adverse Effects as Barriers to Adherence to 
Antiretroviral Therapy in HIV-Infected Patients in Pretoria. SA Fam Pract, 50, 1726-426.  
 
 
 
 
 
 59
Malta, M., Peterson, M. L., Clair, S., Freitas, F., Bastos, F. L. (2005). Adherence to 
antiretroviral therapy study with physicians from Rio de Janeiro, Brazia. Cad. Saude Publica, 
Rio de Janeiro, 21, 1425-1432.  
Mannheimer, S., Friedland, G., Matts, J., Child, C., & Chesney, M. (2002). The consistency of 
adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-
infected persons in clinical trails. Clin Infect Dis, 34, 1115-21. 
 
Manuela de Paoli, M., Grønningsæter, A. B. & Mills, E. (2010) HIV/AIDS, the disability grant 
and ARV adherence. Summary report. Fafo-report 28.  
 
Médecins Sans Frontières. (2010). The reality of access to second-line treatment. Retrieved 
from: http://aids2010.msf.org/2010/the-reality-of-access-to-second-line-treatment. 
Mehta, S., Moore, R.D. and Graham, N.M.H. (1997). Potential Factors Affecting Adherence 
with HIV Therapy. Journal of Acquired Immune Deficiency Syndrome, 11, 1665-1670. 
 
Mermin, J. et al. (2008). Risk Factors for Recent HIV Infection in Uganda, JAMA, 5, 540-549. 
 
Meyer, J. (2000). Using qualitative methods in health related action research. Miller, L. G. & 
Hays, R, D. (2000). Adherence to combination of antiretroviral Therapy: Synthesis of the 
Literature and Clinical Implications. AIDS Read, 10, 177-185.  
 
Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., Wilson, K., 
Buchan, I., Gill, C.J. & Cooper, C. (2006). Adherence to HAART: A Systemic Review of 
Developed and Developing Nation Patient-Reported Barriers and Facilitators. Public Library of 
Service medicine, 11, 2039-2064. 
 
Mombasa ART Project. (2004). Adherence to Antiretroviral therapy in adults: A guide for 
Trainers. Republic of Kenya. 
 
Moralez, R., Figueiredo, V. M., Sinkoc, M.C.B., Gallani, & C. & Tomazin, S.L. (1998) 
.Adherence of patients with AIDS to treatment with HAART medications: difficulties related 
and proposition of attenuating measures. 12th World AIDS Conference, Geneva, Abstract 
42442. 
 
Nachega, J. B., Lehman, D. A., Hlatshwayo, D., Mothopeng, R., Chaisson, R. E. & Karstaedt, 
A. S. (2005).  HIV & AIDS Antiretroviral Treatment Knowledge, attitudes, beliefs, Practices in 
HIV –Infected Adults in Soweto, South Africa. Journal of Acquired immune deficiency 
syndrome, 38, 196-201.  
 
 
 
 
 60
 
Nachega, J. B., Knowlton, A. R., Deluca, A., Schoeman, J. H., Watkinson, L., Efron, A., & 
Maartens, G. (2006). Treatment Supporter to Improve Adherence to Antiretroviral Therapy in 
HIV-Infected South African Adults. JAIDS: Journal of Acquired Immune Deficiency 
Syndromes, 43, 127-133.  
 
National Department of Health South Africa. (2004). Antiretroviral treatment (ART) in adults. 
In: National Anti Retroviral Treatment guidelines. [Online] Available: 
http://www.doh.gov.za/docs/hivaids-progressrep.html  
 
Newman, J ., Hemingway-Foday, J., Freeman, A., Akam, W.,   Balimba, A.,  Kalenga, L.,   
 Mbaya,  M.,   Molu, B. M.,   Mukumbi,  H.,  Niyongabo, T.,  Atibu, J., Azinyue I. &  Kiumbu, 
M.
 
( 2012). Older Adults Accessing HIV Care and Treatment and Adherence in the IeDEA 
Central Africa Cohort AIDS.  Research and Treatment, 1155, 2012-725713. 
Nyika, A. (2007) Ethical and regulatory issues surrounding African traditional medicine in 
context of HIV/AIDS. Dev World Bioeth, 7, 25-34. 
 
Ojikutu, B. & Jack, C., Ramjee, C. (2007). Provision of antiretroviral Therapy in South Africa: 
Unique challenges and Remaining Obstacles. JID, 196, 523-27. 
 
Orrell, C., Bangsberg, D. R. Badri, M. & Wood, E. (2003). Adherence is not a barrier to 
successful antiretroviral therapy in South Africa. AIDS, 17, 1369-75. 
 
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J. & Satten, G. A., et 
al.(1998). Declining morbidity and mortality among patients with advanced human 
immunodeficiency virus infection. The New England  Journal of Medicine, 338, 853-860. 
 
Palitza, K. (2010). HIV Stigma Persists. (IPS), [Online] Available: 
http://ipsnews.net/news.asp?idnews=49904.  
 
Palmira, de F. B., Cibele, C., Francisco, A., Maria, C., Menezes, C. A., Juliana, A., Lorenza, N. 
C., Ricardo, A.C., Mark, D. C. (2005). Non-adherence among patients initiating antiretroviral 
therapy: a challenge for health professional in Brazil. AIDS, 19, 5-13. 
 
Paxton, S. (2002). The Paradox of Public HIV Disclosure. AIDS Care, 4, 559-567. 
 
 
 
 
 
 61
Peltzer, K., Preez, N. F., Preez, N. F., Ramlagan, S. & Fomundam, H. (2008). Use of traditional 
complementary and alternative medicine for HIV patients in Kwazulu-Natal, South Africa.  
BMC Public Health, 1471, 2458- 255.  
 
Peterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagner, Pope, 
C., Ziebland, S. & Mays, N. (2000) Analysing Qualitative Data. British Medical Journal, 320, 
114-116.  
 
Pope, C. Z. & Mays, S. N. (2002). Analysing qualitative data: British Medical Journal, 320, 
114-116.  
 
Pope, C., S. & Mays, N. (1995). Qualitative Research, Reaching the Parts other Methods 
cannot reach: Introduction to Qualitative Methods in Health and Health Services Research. 
British Medical Journal. 311: 109-112.  
 
Pope, C., S. & Mays, N. (1995). Qualitative Research, Reaching the Parts other Methods 
cannot Reach: Introduction to Qualitative Methods in Health and Health Services Research. 
British Medical Journal. 311: 109-112.  
 
Pope, C., Ziebland, S. & May, N. (2000). Analysing Qualitative Data. British Medical Journal, 
320,114-116. 
 
Pope, C. Ziebland, S. & Mays, N. (2000). Qualitative research in healthcare: analyzing qualitative 
data. British Medical Journal, 320(7227), 114-116. 
 
Pratt, R., Robinson, N., Loveday, H., Pellowe, C., Franks, P. & Loveday, C. et al. (1998). 
Improvement in sexual drive and a falling viral load are associated with adherence to anti-
retroviral therapy. International Conference on AIDS, 12, 589-90. Abstract No. 32343). 
 
Rabkin, M., El-Sadr, W. & Abrams, E. (2005). Care and Treatment of HIV/AIDS in Resource- 
Limited Settings. In: The Columbia Clinic Manual. New York: Mailman School of Public 
Health at Columbia University 264.  
 
Reitzer, G. (2006). Contemporary Social Theory and its Classical Roots: The basics (2nd edi.). 
McGraw-Hill. Retrieved March 2008 from "http://en.wikipedia.org/wiki/Stigma. 
 
Robson, C. (1993). Ch. 9 - interview and questionnaire in Robson, C. really world Research. 
Blackwell, 227-243. 
 
 
 
 
 62
 
Roura, M., Busza, J., Wringe, A., Mbata, D., Urassa, M. & Zaba, B. (2009). Barriers to 
Sustaining Antiretroviral Treatment in Kisesa, Tanzania: A Follow-Up Study to Understand 
Attrition from the Antiretroviral Program. AIDS Patient Care & STDs, 23, 203-210.  
 
Ruud, K. W., Srinivas, S. C. & Toverud, E. L. (2009). Antiretroviral therapy in a South African 
public health care setting – facilitating and constraining factors. Southern Med Review, 2, 29-3.  
 
Safren, S. A., Kumarasamy, N., James, R., Raminani, S., Solomon, S. & Mayer, K.H. (2005). 
ART adherence, demographic variables and CD4 outcome among HIV-positive patients on 
antiretroviral therapy in Chennai, India. AIDS Care; 17, 853-62. 
 
Schilder, A. J., Hogg, R. S., Goldstone, I., Stathdee, S., Schechter, M.T. & O'Shaughnessy, 
M.V. (1998). Adult social identity is part of culturally competent HIV care for sexual 
minorities and affects care seeking behaviours and therapeutic adherence. 12th World AIDS 
Conference, Geneva, Abstract 32355. 
 
Schilder, A. J., Hogg, R. S., Goldstone, I., Stathdee, S., Schechter, M. T. & O'Shaughnessy, M. 
V. (1998). Adult social identity is part of culturally competent  HIV care for sexual minorities 
and affects care seeking behaviours and therapeutic adherence. 12th World AIDS Conference, 
Geneva, Abstract 32355. 
 
Schneider, H., Blaauw, D., Gilson, L., Chabikuli, N. & Goudge, J. (2006) Health Systems and 
Access to Antiretroviral Drugs for HIV in Southern Africa: Service Delivery and Human 
Resource Challenges. Reproductive Health Matters, PubMed Abstract,14, 12-23. 
 
Shaikh, N. (2007). Epidemiology prevention and health system. Southern African Journal of 
Medicine, 28, 10-11. 
 
Shaikh, N., Abdullah, F., Lombard, C. J., Smit, L., Bradshaw, D. & Makubalo, L. (2006). 
Masking through averages-intraprovincial heterogeneity in HIV prevalence with the Western 
Cape. SAMJ, 96, 538-543. 
 
Simon, J. M., Frick, P. A., Lockhart, D. & Liebovitz, D. (2002). Mediators of Social 
Support and Antiretroviral Adherence among an Indigent Population in New York City. 
AIDS Patient Care, 16, 431 – 439. 
 
 
 
 
 
 63
Simoni, J., Frick, P. A., Pantalone, D. W. & Turner, B. J. (2003). Antiretroviral 
adherence interventions: a review of current literature and ongoing studies. Top HIV 
Med, 11, 185-98. 
 
Singh, N., Squier, C., Sivek, M., Wagener, M., Nguyen, H. & Yu, V.L. (1996). Determinants of 
compliance with HAART therapy in patients with human immunodeficiency virus: prospective 
assessment with implications for enhancing compliance. AIDS, 8 , 261-269. 
 
Sipler, A. M., Cross, J. T., Lane, D. R., Davis, T. C. & Williams, L. M. (1999). The 
relationship between literacy, race, and adherence to patient HAART therapies. 6th Conference 
on Retroviruses and Opportunistic Infections, Chicago, Abstract, 108. 
South African National AIDS Council. (2007), HIV & AIDS and STI Strategic Plan for South 
Africa 2007 – 2011. Pretoria: SANAC.  
 
Spacek, L. A., Shihab, H. M., Kamya, M. R., Mwesigire, D., Ronald, A.,  Mayanja, H., Moore, 
R. D.,  Bates, M. & Quinn, T. C. (2006). Response to antiretroviral therapy in HIV-infected 
patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis, 15(2), 252-9. 
 
Stommel, M. & Wills, C. E. (2004). Clinical research: concepts and principles for advanced 
practice nurses. Philadelphia: Lippincott Williams & Wilkins. 
 
Stone, P. & Curtis, S. J. (2002). Pharmacy Practice. 3rd ed. London: Pharmaceutical Press 355. 
 
Tapp, C., Milloy, M-J. 1., Kerr, T., Ruth, Z., Guillemi, S., Hogg, R. S., Montaner, J. & Wood, 
E, (2011). Female gender predicts lower access and adherence to antiretroviral therapy in a 
setting of free healthcare. BMC Infectious Diseases, 11,-86, 14 71-2334.  
 
The South African National Strategic Plan for HIV and AIDS, STIs and TB. (2007).  
The South African National Strategic Plan for HIV/ AIDS, STIs and TB (2011). Draft Zero for 
Consultation   
Torpey, K., Kabaso, M., Mutale, L., Kamanga, M., Mwango, A., Simpungwe, J., Suzuki, C. & 
Mukadi, Y. (2008) Adherence Support Workers. A Way to Address Human Resource 
Constraints in Antiretroviral Treatment Programs in the Public Health Setting in Zambia. Plos 
ONE PubMed Abstract , 3-5. 
 
UNAIDS. (2009). Report on the Global AIDS Epidemic. Geneva: UNAIDS.  
 
 
 
 
 64
 
Uthman, O. A. (2008).  Prevalence and Pattern of HIV-Related Malnutrition among Women in 
Sub-Saharan Africa: A Meta-Analysis of Demographic Health Surveys. BMC Public Health, 8-
226. 
 
Uzochukwu, B., Onwujekwe, O., Onoka, A., Okoli, C., Uguru, N. & Chukwuogo, O. (2009).  
Determinants of Non-Adherence to Subsidized Anti-Retroviral Treatment in Southeast Nigeria. 
Health Policy and Planning 24:189–196. Oxford University Press. March 2009. [Online], 
Available:  http://heapol.oxfordjournals.org [Downloaded 06/10/10 10:10 AM].    
 
Van Dyk, A. C. (2001). HIV/AIDS care and counseling: A multidisciplinary approach (2nd ed.) 
Pearson Education. 
 
Van Wyk, B. Strebel, A., Peltzer, K. & Skinner, D. (2006). Community-level Behavioural 
interventions for HIV Prevention in Sub-Saharan Africa.  Cape Town. HSRC  Press.  
 
Wagner, G. J. (2002). Predictors of antiretroviral adherence as measured by self report, 
electronic monitoring, and medication diaries. AIDS Care, 16, 599-608.  
 
Wanyama. J., Castelnuovo, B., Wandera, B., Mwebaze, P., Kambugu, A., Bangsberg, D. R. & 
Kamya, M. R. (2007). Belief in divine healing can be a barrier to antiretroviral therapy 
adherence in Uganda. Aids, 21, 1486-1487. 
 
Watt, M. H., Maman, S., Earp, J. A., Eng, E., Setel, P. W. & Golin, C. E., et al.  (2009). “It's all 
the time in my mind”: facilitators of adherence to antiretroviral therapy in a Tanzanian 
setting. Social Science & Medicine, 68, 1793–180. 
 
Weidle, P. J., Malamba, S., Mwebaze, R., Sozi, C., Rukundo, G., Downing, R., Hanson, 
D., Ochola, D., Mugyenyi, P., Mermin, J., Samb, B. & Lackritz, E. (2002). Assessment of a 
pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug 
resistance. Lancet, 9326, 34-40.  
 
Weiser, S. D., Tuller, D. M., Frongillo, E. A., Senkungu, J. & Mukiibi, N et al. (2010). Food 
Insecurity as a Barrier to Sustained Antiretroviral Therapy Adherence in Uganda. Plos ON, 5- 4.  
Weiser, S., Wolfe, W., Bangsberg, D., Thior, I., Gilbert, P., Makhena, J., Kebaabetswe, P., 
Dickenson, D., Kgosidialwa, M., Essex, M. & Marlink, R. (2003). Barriers to Antiretroviral 
 
 
 
 
 Therapy Adherence for Patients Living with HIV infection and AIDS in Botswana. 
Acquired Immune Deficiency Syndromes
 
Wenger, N., Gifford, A., Liu, H., Chesney, M. & Golin, C. (1999). Patient
PEPFAR. (2008). Task Shifting: Global Recommendations and Guidelines.
 
Williams, A. & Friedland, G. (1997). Adherence, compliance, and HAART. 
Care, 9 (7), 51-53. 
 
Williams, M., Tutty, L. M. &
Itasca: Peacock.  
Wiwanitkit, V. (2003). The use of CAM by HIV
Ther Med, 11, 39-41.  
 
World Health Organization 
Action. Geneva, Switzerland. 1
 
World Health Organization 
AIDS. Geneva: World Health Organization. 
 
World Health Organization
infection in adults and adolescents: Recommendations for public health approach. 
from http://www.who.int/hiv/pub/arv/adult/en/index.html
 
World Health Organization (2010). 
adolescents. Recommendations for a public health approach.  ISBN, 9789241599764.
 
Yared, M., Mela, R., Sanders, Tibebu
Ethiopia. Washington, DC: Futures Group, 
 
Zorrilla, C. D.  (2000). Antiretroviral combination therapy in HIV
are their responses different? 
 
Zou, J., Yaman aka, Y., Joh
and HIV in Tanzania: influence of religious beliefs on HIV disclosure, and treatment attitudes. 
BMC Public Health, 141, 2458
 
 
65
, 34:281-288.  
 
 Grinnel, R. M. (1995).  Research in social work: an introduction. 
–positive patients in Thailand.  
(2003). Adherence to Long-term Therapies: 
-194. 
(2006) Taking stock: Health worker shortages and the response to 
 
 (2006). HIV/AIDS Programme. Antiretroviral therapy for HIV 
.  
Antiretroviral therapy for HIV infection in adults and
, S., & Emmart, P. (2010). Equity and Access to ART in 
Health Policy Initiative, Task Order 1.
-1 infected women and men: 
Int J Fertil Womens Med, 45(2):195-9. 
n, M., Watt, M., Osternmann, J. & Thielman, N. (2009). Religious 
-75.  
Journal of 
 WHO, UNAIDS, 
Geneva.  
AIDS Clinical 
Complement 
Evidence for 
Retrieved 
 
 
 
 
 
 
 
 UNIVERSITY of the
Barriers to Adherence to A
 
INTRODUCTION  
I am Azia Ivo Nchendia, a Master
Science at the University of the Western Cape. As part of my Mini
study to explore the barriers to adherence to antiretroviral treatment in Vredenburg. I will like 
to take some of your time to interview you in connection to the above study using an audio tape 
recorder. There are no risks of participating in this study and all information
me will be treated strictly as confidential and no one will have access
the researchers. All information collected from you will be preserved and stored in a way that 
confidentiality will be strictly maintained.  Your participation in the study is voluntary and you 
may withdraw from the study at any
 
The results from this study will be beneficial in developing strategies to effectively promote 
optima adherence to ARV medications by HIV/
If you would like to participate in this study, please sign at the bottom of this letter.  
 
 
You can contact Mr. Azia Ivo Nchendia on telephone number at work 0215105055 or at
on 0782015547. Or e-mail. aziaan@yahoo.com
 
 
 
Signature __________________________
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APPENDIX A  
Consent Form 
 
 
 WESTERN CAPE
School of Public Health 
 
 
ntiretroviral Treatment in Vredenburg, Cape Town 
’s Degree Student of the Department of Community Health 
-thesis I am carrying out a 
 to this information except 
 time without sustaining any penalty for your withdrawer. 
AIDS patients in this community. 
 or aziaanster@gamil.com
         Date __________________________
 
  
 that you will give 
 
 
 
 home 
  
 
 
 
 
 
 Questionnaire to non-adhering HIV/
 
UNIVERSITY of the WESTERN CAPE
 
Barriers to Adherence to Antiretroviral T
 
Name of the health facility: 
Name of interviewer        : 
Date of interview       : 
 
Short introductory remarks, explain the purpose of the study, and define what is meant by 
adherence, purpose of the discussion and reassurance about confidentiality.
 
Introduction of the interviewer(s), and study
 
1) Sociodemographic information of the n
programme in the Vredenburg H
 
a) Sex  
b) Age 
c) Educational level  
d)  Who they live with  
e) Distance from the facility 
 
i) How do you get to the facility? 
ii) Are you employed? If not what is your source of income? (probe, prostitution, stealing etc) 
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APPENDIX B 
AIDS patients on the ART Programme in the 
 
School of Public Health 
 
reatment in Vredenburg, Cape Town
__________________________________________________
__________________________________________________  
__________________________________________________
 
on-adhering HIV/AIDS patients on the ART 
ospital 
 
 
None, primary, secondary, tertiary etc. 
Spouse, children, house girl, friend etc. 
 In Km etc  
 
Vredenburg Hospital 
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2). Medical history of the patient  
a) When and where you were first diagnosed of HIV?  
b) What made you decide to go for testing? 
c) Did you start ART immediately after being diagnosed HIV (+Ve)? Can you kindly 
explain to me a little further what happened after you were diagnosed HIV (+Ve)? 
d) When did you start taking your ART?  
e) How do you feel about your health since you started the treatment?  
f) How many times are you supposed to take the medications?  
g)  What helps you to take the medication as instructed by the health officers?  
h) What makes it difficult for you to take your ART medications as instructed by the doctor? 
i) Does your family know that you are on ART? 
j) How is your family treating you now that they know you are on ART treatment? 
k) What factors or things in the community help you to live positively with your HIV status? 
l) What factors or things in the community make it difficult for you to live positively with 
your HIV status? 
m) What do you perceive as the biggest problem regarding taking your ART treatment? 
n) Do you take your ART medications as prescribe?  Why and why not?  Can you please 
explain to me a bit further?  
o) Are there times when you have failed to take medications as prescribed by the doctor?  
p) What are the reasons why you have not visited the hospital to take your medication etc?  
q) Do you have friends who are on ART who do not take medications as prescribed by the 
doctor? What reasons do they give for   not take medications as prescribed by the doctor 
Probe the possible obstacles for adherence such as drugs availability, attitudes of health 
workers, financial etc. 
r)  Who do you think could be done to improve adherence?  
s) Is there anything else you will like to tell me about HIV and ART medications?  
 
 
 
 
